<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57603</article-id><article-id pub-id-type="doi">10.7554/eLife.57603</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Endothelial TGF-β signaling instructs smooth muscle cell development in the cardiac outflow tract</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-122156"><name><surname>Boezio</surname><given-names>Giulia LM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7776-7985</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-114962"><name><surname>Bensimon-Brito</surname><given-names>Anabela</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1663-2232</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182873"><name><surname>Piesker</surname><given-names>Janett</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80789"><name><surname>Guenther</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-174826"><name><surname>Helker</surname><given-names>Christian SM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0427-5338</contrib-id><email>christian.helker@biologie.uni-marburg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" corresp="yes" id="author-7189"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0382-0026</contrib-id><email>Didier.Stainier@mpi-bn.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Scientific Service Group Microscopy, Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Bioinformatics and Deep Sequencing Platform, Max Planck Institute for Heart and Lung Research</institution><addr-line><named-content content-type="city">Bad Nauheim</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Senior Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Meilhac</surname><given-names>Sigolène M</given-names></name><role>Reviewing Editor</role><aff><institution>Imagine-Institut Pasteur</institution><country>France</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Philipps University Marburg, Faculty of Biology, Cell Signaling and Dynamics, Marburg, Germany</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>29</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57603</elocation-id><history><date date-type="received" iso-8601-date="2020-04-06"><day>06</day><month>04</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-09"><day>09</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Boezio et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Boezio et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57603-v1.pdf"/><abstract><p>The development of the cardiac outflow tract (OFT), which connects the heart to the great arteries, relies on a complex crosstalk between endothelial (ECs) and smooth muscle (SMCs) cells. Defects in OFT development can lead to severe malformations, including aortic aneurysms, which are frequently associated with impaired TGF-β signaling. To better understand the role of TGF-β signaling in OFT formation, we generated zebrafish lacking the TGF-β receptor Alk5 and found a strikingly specific dilation of the OFT: <italic>alk5-/-</italic> OFTs exhibit increased EC numbers as well as extracellular matrix (ECM) and SMC disorganization. Surprisingly, endothelial-specific <italic>alk5</italic> overexpression in <italic>alk5</italic>-/- rescues the EC, ECM, and SMC defects. Transcriptomic analyses reveal downregulation of the ECM gene <italic>fibulin-5,</italic> which when overexpressed in ECs ameliorates OFT morphology and function. These findings reveal a new requirement for endothelial TGF-β signaling in OFT morphogenesis and suggest an important role for the endothelium in the etiology of aortic malformations.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>outflow tract</kwd><kwd>TGF-β</kwd><kwd>Endothelium</kwd><kwd>smooth muscle cells</kwd><kwd>cellular cross-talk</kwd><kwd>extracellular matrix</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max-Planck-Gesellschaft</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Boezio</surname><given-names>Giulia LM</given-names></name><name><surname>Bensimon-Brito</surname><given-names>Anabela</given-names></name><name><surname>Piesker</surname><given-names>Janett</given-names></name><name><surname>Guenther</surname><given-names>Stefan</given-names></name><name><surname>Helker</surname><given-names>Christian SM</given-names></name><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB834</award-id><principal-award-recipient><name><surname>Helker</surname><given-names>Christian SM</given-names></name><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>ZMOD 694455</award-id><principal-award-recipient><name><surname>Stainier</surname><given-names>Didier YR</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Alk5/TGF-β signaling is required in the endothelium to orchestrate zebrafish cardiac outflow tract morphogenesis, regulating smooth muscle cell and extracellular matrix organization.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The cardiovascular system is essential to deliver blood to the entire organism. Within the heart, however, the high pressure deriving from ventricular contractions needs to be buffered to avoid damage to the connecting vessels. The cardiac outflow tract (OFT), located at the arterial pole of the heart, fulfills this role and is a vital conduit between the heart and the vascular network (<xref ref-type="bibr" rid="bib51">Kelly and Buckingham, 2002</xref>; <xref ref-type="bibr" rid="bib99">Sugishita et al., 2004</xref>). Its importance is confirmed by the fact that errors in OFT morphogenesis lead to almost 30% of all congenital heart defects (CHD) in humans (<xref ref-type="bibr" rid="bib79">Neeb et al., 2013</xref>). These malformations include defects in the alignment and septation of the OFT, such as persistent truncus arteriosus (PTA), transposition of the great arteries and overriding aorta, as well as coarctation or dilation of the arteries exiting the heart (<xref ref-type="bibr" rid="bib79">Neeb et al., 2013</xref>; <xref ref-type="bibr" rid="bib3">Anderson et al., 2016</xref>). However, the etiology of these malformations remains unclear, due to their multifactorial causes and the complex interplay between the different cell types in the developing heart.</p><p>In all vertebrates, the development of the OFT starts with the formation of a simple tube lined by endothelial cells (ECs) and surrounded by myocardium, both derived from late-differentiating second heart field (SHF) progenitors (<xref ref-type="bibr" rid="bib74">Mjaatvedt et al., 2001</xref>; <xref ref-type="bibr" rid="bib51">Kelly and Buckingham, 2002</xref>; <xref ref-type="bibr" rid="bib71">Meilhac et al., 2014</xref>). Later, this tube becomes surrounded by smooth muscle cells (SMCs) of SHF and neural crest origins (<xref ref-type="bibr" rid="bib2">Anderson et al., 2003</xref>; <xref ref-type="bibr" rid="bib90">Rothenberg et al., 2003</xref>; <xref ref-type="bibr" rid="bib113">Waldo et al., 2005b</xref>; <xref ref-type="bibr" rid="bib3">Anderson et al., 2016</xref>). Eventually, in mammals, the OFT undergoes septation, cushion formation, and rotation, giving rise to the mature structure that forms the trunk of the great arteries (<xref ref-type="bibr" rid="bib90">Rothenberg et al., 2003</xref>; <xref ref-type="bibr" rid="bib6">Bajolle et al., 2006</xref>). In zebrafish, the recruitment of SHF progenitors from the anterior lateral plate mesoderm to the OFT starts around 26 hours post-fertilization (hpf) and proceeds in multiple waves (<xref ref-type="bibr" rid="bib41">Hami et al., 2011</xref>; <xref ref-type="bibr" rid="bib122">Zhou et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Jahangiri et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Paffett-Lugassy et al., 2017</xref>; <xref ref-type="bibr" rid="bib25">Felker et al., 2018</xref>). Starting at 54–56 hpf, a few immature SMCs expressing elastin appear at the arterial pole of the heart (<xref ref-type="bibr" rid="bib35">Grimes et al., 2006</xref>; <xref ref-type="bibr" rid="bib122">Zhou et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Jahangiri et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Felker et al., 2018</xref>). From 72 hpf onwards, most of the OFT is surrounded by SMCs expressing elastin, fibronectin and aggrecan (<xref ref-type="bibr" rid="bib73">Miao et al., 2007</xref>; <xref ref-type="bibr" rid="bib87">Rambeau et al., 2017</xref>; <xref ref-type="bibr" rid="bib23">Duchemin et al., 2019</xref>), although they still lack the expression of specific markers. Eventually, a few neural crest cells also colonize the region (<xref ref-type="bibr" rid="bib13">Cavanaugh et al., 2015</xref>). In zebrafish, the OFT does not septate and forms what is considered a ‘subsidiary chamber’ – the bulbus arteriosus (<xref ref-type="bibr" rid="bib35">Grimes et al., 2006</xref>; <xref ref-type="bibr" rid="bib37">Grimes and Kirby, 2009</xref>; <xref ref-type="bibr" rid="bib36">Grimes et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Knight and Yelon, 2016</xref>).</p><p>In terms of the cellular contributions to OFT development, most of the attention has been focused on the SMCs, cardiac neural crest, and CMs (<xref ref-type="bibr" rid="bib51">Kelly and Buckingham, 2002</xref>; <xref ref-type="bibr" rid="bib9">Buckingham et al., 2005</xref>; <xref ref-type="bibr" rid="bib112">Waldo et al., 2005a</xref>; <xref ref-type="bibr" rid="bib113">Waldo et al., 2005b</xref>). However, given the role of the endothelium in the formation of other structures including the cardiac ventricles (<xref ref-type="bibr" rid="bib58">Lee et al., 1995</xref>; <xref ref-type="bibr" rid="bib72">Meyer and Birchmeier, 1995</xref>; <xref ref-type="bibr" rid="bib89">Rasouli and Stainier, 2017</xref>; <xref ref-type="bibr" rid="bib88">Rasouli et al., 2018</xref>), ECs are also likely to play major roles in OFT formation.</p><p>Multiple signaling pathways including BMP, Notch, FGF, Wnt, and TGF-β have been implicated in OFT development (<xref ref-type="bibr" rid="bib79">Neeb et al., 2013</xref>). In particular, mutations in several of the <italic>TGF-β</italic> family members have been associated with severe congenital heart malformations, including PTA and aneurysm of the great vessels (<xref ref-type="bibr" rid="bib106">Todorovic et al., 2007</xref>; <xref ref-type="bibr" rid="bib31">Gillis et al., 2013</xref>; <xref ref-type="bibr" rid="bib104">Takeda et al., 2018</xref>). Despite the clear importance of TGF-β signaling in the development and homeostasis of the OFT and connecting vessels, the molecular mechanisms underlying these defects remain elusive, due to the context-dependent and controversial role of this pathway which exhibits complex interactions with other signaling pathways (<xref ref-type="bibr" rid="bib69">Massagué, 2012</xref>; <xref ref-type="bibr" rid="bib16">Cunha et al., 2017</xref>; <xref ref-type="bibr" rid="bib34">Goumans and Ten Dijke, 2018</xref>; <xref ref-type="bibr" rid="bib121">Zhang, 2018</xref>). In fact, loss-of-function mutations in many <italic>TGF-β</italic> genes lead to an unexpected hyperactivation of downstream signaling after the initials manifestation of the symptoms (<xref ref-type="bibr" rid="bib49">Jones et al., 2009</xref>; <xref ref-type="bibr" rid="bib63">Lin and Yang, 2010</xref>; <xref ref-type="bibr" rid="bib66">Mallat et al., 2017</xref>; <xref ref-type="bibr" rid="bib104">Takeda et al., 2018</xref>).</p><p>Activin receptor-like kinase 5 (Alk5, aka Tgfbr1) is the main type I receptor of the TGF-β signaling pathway. In mouse, <italic>Alk5</italic> expression is present specifically in the great arteries and the heart, enriched in the SMC layer of the aorta (<xref ref-type="bibr" rid="bib93">Seki et al., 2006</xref>). A global <italic>Alk5</italic> mutation in mouse leads to embryonic lethality due to brain hemorrhage and presumed cardiac insufficiency (<xref ref-type="bibr" rid="bib11">Carvalho et al., 2007</xref>). Notably, these phenotypes are recapitulated by the EC-specific deletion of <italic>Alk5</italic> (<xref ref-type="bibr" rid="bib96">Sridurongrit et al., 2008</xref>), although their cause remains unclear. Conversely, despite its reported expression pattern, loss of <italic>Alk5</italic> in mouse cardiomyocytes, pericytes or SMCs does not lead to any obvious defects during the development of the heart or great vessels (<xref ref-type="bibr" rid="bib96">Sridurongrit et al., 2008</xref>; <xref ref-type="bibr" rid="bib17">Dave et al., 2018</xref>).</p><p>Despite the evidence for a potential role for ALK5 in the endothelium (<xref ref-type="bibr" rid="bib96">Sridurongrit et al., 2008</xref>), most studies in OFT and aortic pathologies, such as aortic aneurysms, have been focused on the role of TGF-β signaling in SMCs and not ECs (<xref ref-type="bibr" rid="bib15">Choudhary et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Guo and Chen, 2012</xref>; <xref ref-type="bibr" rid="bib31">Gillis et al., 2013</xref>; <xref ref-type="bibr" rid="bib118">Yang et al., 2016</xref>; <xref ref-type="bibr" rid="bib104">Takeda et al., 2018</xref>). In particular, aneurysms have been described as a weakening of the aortic wall due to SMC-specific defects, resulting in the dissection of the vessel (<xref ref-type="bibr" rid="bib104">Takeda et al., 2018</xref>). Only recently have a few studies started considering the endothelium as a potential therapeutic target in aortic pathologies (<xref ref-type="bibr" rid="bib108">van de Pol et al., 2017</xref>; <xref ref-type="bibr" rid="bib101">Sun et al., 2018</xref>). The close proximity of ECs with SMCs makes their cross-talk essential for aortic development and homeostasis (<xref ref-type="bibr" rid="bib62">Lilly, 2014</xref>; <xref ref-type="bibr" rid="bib98">Stratman et al., 2017</xref>; <xref ref-type="bibr" rid="bib92">Segers et al., 2018</xref>). However, the early lethality of the <italic>Alk5</italic> global and EC-specific KO mice prevents a deeper investigation of the role of this gene in heart and OFT development.</p><p>The use of zebrafish as a model system can help overcome the issues associated with early embryonic lethality resulting from severe cardiovascular defects (<xref ref-type="bibr" rid="bib97">Stainier and Fishman, 1994</xref>). Moreover, this system allows a detailed <italic>in vivo</italic> analysis of the phenotype and the assessment of cardiovascular function during embryogenesis thanks to its amenability to live imaging. Overall, due to the conserved features of OFT development amongst vertebrates (<xref ref-type="bibr" rid="bib37">Grimes and Kirby, 2009</xref>; <xref ref-type="bibr" rid="bib36">Grimes et al., 2010</xref>), the zebrafish could help one to obtain new insights into the role of TGF-β signaling in OFT development and disease.</p><p>Here, we generated a zebrafish <italic>alk5</italic> mutant and observed a severe dilation of the developing OFT. We show that this phenotype results from early defects in EC proliferation, followed by aberrant SMC proliferation and organization. Live imaging and transcriptomic analyses further reveal an Alk5-dependent alteration in extracellular matrix (ECM) composition. Notably, we show that restoring Alk5 in the endothelium is sufficient to rescue the OFT phenotype, including the SMC organization defects. Moreover, we identify the ECM gene <italic>fibulin-5</italic> (<italic>fbln5</italic>) as a target of Alk5 signaling able to partially rescue the <italic>alk5</italic> mutant phenotype when overexpressed in ECs, providing a new therapeutic target for various aortic malformations.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Loss of Alk5 causes specific defects in cardiac OFT formation</title><p>Mammalian <italic>TgfbrI/Alk5</italic> has two paralogs in zebrafish, <italic>alk5a</italic> and <italic>alk5b,</italic> and from multiple datasets (<xref ref-type="bibr" rid="bib83">Pauli et al., 2012</xref>; <xref ref-type="bibr" rid="bib117">Yang et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Gauvrit et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Mullapudi et al., 2018</xref>), we found <italic>alk5b</italic> to be the highest expressed paralog during embryogenesis. To investigate its expression, we performed <italic>in situ</italic> hybridization and generated a transgenic reporter line<italic>, TgBAC(alk5b:EGFP),</italic> by bacterial artificial chromosome (BAC) recombineering. We detected <italic>alk5b</italic> expression in the neural tube starting at 30 hpf and in the gut at 72 hpf (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D’</xref>). Notably, in the developing cardiovascular system, <italic>alk5b</italic> reporter expression appears to be restricted to the heart (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>), as we could not detect GFP expression in any other vascular beds (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B,B’</xref>). Within the heart, we detected <italic>alk5b</italic> expression in the OFT (<xref ref-type="fig" rid="fig1">Figure 1A–B’’</xref>), where it is localized in both ECs and SMCs (<xref ref-type="fig" rid="fig1">Figure 1B’, B’’</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Loss of Alk5 function causes specific defects in cardiac OFT formation.</title><p>(<bold>A</bold>) Schematic of the zebrafish heart and connecting vessels at 78 hpf; ventral view; black, endothelium/endocardium. (<bold>B–B’’</bold>) Confocal images showing <italic>TgBAC(alk5b</italic>:EGFP) expression (green) in the 78 hpf zebrafish heart. White, ECs; arrowheads, SMCs; boxed area shown in <bold>B’</bold> and <bold>B’’</bold>; white dotted lines outline the OFT; magenta dotted lines outline ECs. (<bold>C–H</bold>) Confocal images (<bold>C, D, F, G</bold>) and quantification (<bold>E, H</bold>) of OFT width in <italic>alk5+/+</italic> and <italic>alk5-/</italic>- embryos at 30 (<bold>C–E</bold>) and 54 (<bold>F–H</bold>) hpf. Orange line shows OFT width graphed in <bold>E</bold> and <bold>H</bold>. (<bold>I–K</bold>) Frames of confocal movies of beating hearts (<bold>I, J</bold>) and quantification of OFT expansion (<bold>K</bold>) at 78 hpf. For details about the quantifications, see Materials and methods ‘Defining the landmarks of the OFT’. (<bold>L, L’</bold>) Frames of confocal movies of 96 hpf <italic>alk5-/</italic>- beating hearts during ventricular diastole (<bold>L</bold>) and systole (<bold>L’</bold>). Pink dotted lines outline ECs surrounding the rupture; arrows point to the site of EC rupture; yellow dotted lines outline the OFT. (<bold>M, N</bold>) Confocal images of 96 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- OFTs showing the accumulation (arrowheads) of FITC-Dextran (green) between the SMCs in <italic>alk5-/</italic>- OFTs (7/11; <italic>alk5+/+</italic> 0/10). Magenta, ECs; dotted lines outline the OFT. (<bold>C–G</bold>) Maximum intensity projections. (<bold>B, I–N</bold>) Single confocal planes. (<bold>E, H, K</bold>) Plot values represent mean ± SD; p values from <italic>t</italic>-tests. A- atrium, V- ventricle. Scale bars: (<bold>B, C–L’</bold>) 20 μm; (<bold>B’, B’’</bold>) 10 μm; (<bold>M, N</bold>) 5 μm. See also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>alk5</italic> expression and function in zebrafish embryos and larvae.</title><p>(<bold>A–B’</bold>) Confocal images showing <italic>TgBAC(alk5b:</italic>EGFP) expression (green/white) in 30 (<bold>A</bold>) and 52 (<bold>B</bold>) hpf zebrafish embryos. Expression is high in the neural tube (NT, <bold>B</bold>). (<bold>C–D’</bold>) <italic>in situ</italic> hybridization showing the expression of <italic>alk5b</italic> in 30 and 72 hpf animals. Arrowhead, gut; boxed areas shown in <bold>C’</bold> and <bold>D’</bold>. (<bold>E</bold>) Schematics of wild-type and mutated Alk5 proteins. Black and white stars indicate the site of the corresponding mutations in <italic>alk5a</italic> and <italic>alk5b,</italic> respectively, and the black rectangle represents new sequence downstream of the mutation. (<bold>F</bold>) <italic>alk5a</italic> and <italic>alk5b</italic> mRNA levels in 30 hpf <italic>alk5+/+</italic>, <italic>alk5a-/-</italic> and <italic>alk5b-/-</italic> embryos; means ± SD; p values from Mann Whitney tests; average Ct values are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. (<bold>G–J</bold>) Brightfield images of 96 hpf <italic>alk5+/+, alk5a-/-, alk5b-/-,</italic> and <italic>alk5-/</italic>- larvae. Arrowheads, lack of swim bladder; arrow, pericardial edema. (<bold>K–L</bold>) Confocal images of OFT and connecting vessels in 78 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larvae (n &gt; 30). Asterisk, absence of the VA in <italic>alk5</italic> mutants. (<bold>M</bold>) Quantification of DA diameter in 56 and 96 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- animals. The same animals were analyzed at the two different time-points; means ± SD. (<bold>N, O</bold>) Confocal images of 78 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- hearts (n &gt; 30). (<bold>P</bold>) Quantification of heart rate in 78 hpf <italic>alk5+/+</italic> (n = 6) and <italic>alk5-/-</italic> (n = 11) larvae; means ± SD; p values from Mann Whitney test. SP- signal peptide, RD- receptor domain, TM- transmembrane domain, GS- glycine-serine rich domain, STK- serine-threonine kinase domain, A- atrium, V- ventricle, NT- neural tube, DA- dorsal aorta, PCV- posterior cardinal vein, VA- ventral artery, AA1- aortic arch 1. Scale bars: (<bold>A, A’, C-D’ G-J</bold>) 200 μm; (<bold>B, B’</bold>) 50 μm; (<bold>K–O</bold>) 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig1-figsupp1-v1.tif"/></fig><media id="fig1video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig1-video1.mp4"><label>Figure 1—video 1.</label><caption><title>Confocal video of the beating heart of a <italic>Tg(kdrl:EGFP) alk5+/+</italic> larva at 78 hpf, showing the OFT expansion.</title></caption></media><media id="fig1video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig1-video2.mp4"><label>Figure 1—video 2.</label><caption><title>Confocal video of the beating heart of a <italic>Tg(kdrl:EGFP) alk5-/</italic>- larva at 78 hpf, showing the OFT expansion.</title></caption></media><media id="fig1video3" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig1-video3.mp4"><label>Figure 1—video 3.</label><caption><title>Brightfield video of the beating heart of the <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larvae shown in <xref ref-type="video" rid="fig1video1">Figure 1—videos 1</xref> and <xref ref-type="video" rid="fig1video2">2</xref> at 78 hpf, showing blood flow in the OFT.</title></caption></media><media id="fig1video4" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig1-video4.mp4"><label>Figure 1—video 4.</label><caption><title>Confocal video of the beating heart of a <italic>Tg(kdrl:EGFP) alk5-/</italic>- larva at 96 hpf, showing a hole in the endothelial lining of the OFT.</title><p>Arrow points to the site of EC rupture.</p></caption></media></fig-group><p>In order to investigate Alk5 function, we used CRISPR/Cas9 technology to generate mutants for <italic>alk5a</italic> and <italic>alk5b</italic>. We obtained a 4 bp and a 8 bp deletion in <italic>alk5a</italic> and <italic>alk5b,</italic> respectively, each leading to the predicted generation of truncated proteins, lacking the kinase domain (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Moreover, <italic>alk5a</italic> and <italic>alk5b</italic> mutant mRNA levels are decreased in the respective mutant fish while the other paralog does not appear to be upregulated, suggesting mutant mRNA degradation but a lack of transcriptional adaptation (<xref ref-type="bibr" rid="bib24">El-Brolosy et al., 2019</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). Single <italic>alk5a</italic> and <italic>alk5b</italic> mutant larvae do not exhibit any gross morphological defects, other than the lack of inflation of the swim bladder in <italic>alk5b-/-</italic> larvae (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G–I</xref>). Therefore, to achieve a complete blockade of Alk5 signaling, we generated <italic>alk5a</italic>, <italic>alk5b</italic> double mutants (<italic>alk5a-/-;alk5b-/-</italic>), hereafter referred to as <italic>alk5</italic> mutants. Loss of Alk5 function does not lead to early developmental defects until 72 hpf, when <italic>alk5-/</italic>- larvae start exhibiting pericardial edema, more evident at 96 hpf (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J</xref>), suggesting defective cardiac function. By analyzing heart morphology in live <italic>Tg(kdrl:EGFP) alk5-/</italic>- embryos, we observed a specific increase in OFT width by 54 hpf (<xref ref-type="fig" rid="fig1">Figure 1C–H</xref>). Live imaging of beating hearts showed that, by 78 hpf, the dilation of the <italic>alk5</italic> mutant OFT between systole and diastole is more than twice as large as in wild type (<xref ref-type="fig" rid="fig1">Figure 1I–K</xref>; <xref ref-type="video" rid="fig1video1">Figure 1—videos 1</xref> and <xref ref-type="video" rid="fig1video2">2</xref>). This abnormal expansion of the OFT is accompanied by its inability to pump blood into the connecting vessels, leading to retrograde flow into the ventricle (<xref ref-type="video" rid="fig1video3">Figure 1—video 3</xref>).</p><p>In 78 hpf wild-type zebrafish, the OFT is connected to the aortic arches by a single vessel, the ventral aorta (VA) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>). <italic>alk5-/</italic>- animals fail to form this vessel; instead, they display two independent vessels from the OFT to the left and right aortic arches (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1L</xref>). Furthermore, a few <italic>alk5</italic> mutant OFTs exhibited clear ruptures in their endothelial layer at 96 hpf (<xref ref-type="fig" rid="fig1">Figure 1L,L’</xref>; <xref ref-type="video" rid="fig1video4">Figure 1—video 4</xref>). To investigate this phenotype, we injected dextran into the circulation and 7 out of 11 <italic>alk5-/</italic>- larvae displayed dextran accumulation between the ECs and SMCs in the OFT and in the interstitial space amongst SMCs, a phenotype not observed in <italic>alk5+/+</italic> larvae (n = 10; <xref ref-type="fig" rid="fig1">Figure 1M,N</xref>). Notably, the cardiovascular defects in <italic>alk5</italic> mutant fish are restricted to the OFT and the VA, while all other vascular beds appear morphologically unaffected. The diameter of the dorsal aorta (DA) appears unaffected in <italic>alk5</italic> mutants compared with wild-type siblings at 56 and 96 hpf (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1M</xref>), and the atrium and ventricle appear correctly shaped at 78 hpf (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1N,O</xref>). However, after the onset of the OFT phenotype, <italic>alk5-/</italic>- larvae also exhibit retrograde blood flow through the atrioventricular canal (1/6 <italic>alk5</italic> +/+, 9/10 <italic>alk5-/-</italic>; data not shown), despite an unaffected heart rate (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1P</xref>). Altogether, these defects lead to the lack of blood flow in the trunk by 120 hpf, and consequently, the death of <italic>alk5-/</italic>- larvae by 7 dpf.</p><p>Taken together, these results identify a previously unknown and specific requirement for Alk5 in OFT morphogenesis, structural integrity, and function.</p></sec><sec id="s2-2"><title>The Smad3 signaling axis is activated early in OFT ECs and downregulated in <italic>alk5</italic> mutants</title><p>Since Alk5 is the main type I receptor of the TGF-β signaling pathway, we wanted to investigate the pathway activity. Therefore, we analyzed the activation of Smad3 which, together with Smad2, is the main effector of TGF-β signaling upon its phosphorylation by the receptor. To this aim, we first took advantage of a Smad3-responsive element reporter line (<italic>Tg(12xSBE:EGFP) </italic><xref ref-type="bibr" rid="bib12">Casari et al., 2014</xref>) and observed an enriched GFP signal in the OFT at 24 and 75 hpf (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B’</xref>). In addition, we performed immunostaining on wild-type embryos and larvae for the phosphorylated form of Smad3 (p-Smad3). P-Smad3 immunostaining was detectable in the heart as early as 24 hpf (<xref ref-type="fig" rid="fig2">Figure 2A,A’</xref>), and it persisted until 75 hpf (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C,C’</xref>), exhibiting a pattern in the OFT consistent with the expression of the <italic>Tg(SBE:EGFP)</italic> reporter (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D,D’</xref>). Of note, at 24 hpf, the p-Smad3 OFT signal was strongly enriched in ECs compared with the surrounding cells (2 ± 0.5 folds higher in ECs), while this enrichment was lost by 75 hpf (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Moreover, we detected a 1.7 ± 0.3 fold higher p-Smad3 signal in OFT ECs compared with ECs in the rest of the heart (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). These data suggest that while <italic>alk5b</italic> reporter expression is broadly detected in the heart and in OFT ECs and SMCs (<xref ref-type="fig" rid="fig1">Figure 1</xref>), Alk5 signaling is more prominent in OFT ECs at early stages.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>p-Smad3 is observed in OFT ECs at 24 hpf and reduced in <italic>alk5</italic> mutants.</title><p>(<bold>A, A’</bold>) 24 hpf <italic>Tg(kdrl:EGFP) alk5+/+</italic> hearts immunostained for p-Smad3 (white). Green, ECs; magenta, CMs. (<bold>B, C</bold>) Intensity ratio of p-Smad3 immunostaining (normalized to DAPI) between ECs and surrounding cells at 24 and 75 hpf (<bold>B</bold>) and between OFT ECs and heart ECs in 24 hpf <italic>alk5+/+</italic> embryos (<bold>C</bold>). Every dot represents the ratio for one embryo. (<bold>D–E’</bold>) 24 hpf <italic>Tg(kdrl:EGFP) alk5+/+</italic> (<bold>D</bold>) and <italic>alk5-/-</italic> (<bold>E</bold>) hearts immunostained for p-Smad3 (white). (<bold>F</bold>) Quantification of p-Smad3 immunostaining (normalized to DAPI) in ECs and surrounding cells comparing 24 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- OFTs. (<bold>G–J</bold>) Confocal images of the OFT in 75 hpf <italic>Tg(kdrl:EGFP) alk5+/- (alk5a-/-;alk5b+/-;</italic> <bold>G, H</bold>) and <italic>alk5-/-</italic> (<bold>I, J</bold>) larvae treated with DMSO (<bold>G, I</bold>) or SIS3 (<bold>H, J</bold>) from 36 until 75 hpf. Asterisks point to the absence of the VA. (<bold>K</bold>) OFT maximum area in 75 hpf larvae treated with DMSO or SIS3. (<bold>A–J</bold>) Dotted lines outline the OFT ECs. (<bold>B, C, F, K</bold>) Plot values represent means ± SD; p values from Mann Whitney (<bold>B, K</bold>) and <italic>t-</italic>test (<bold>F</bold>). In K, p values refer to the comparisons highlighted. Scale bars: (<bold>A, A’, D–E’</bold>) 20 μm; (<bold>G–J</bold>) 15 μm. See also <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig2sdata2">2</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantification of p-Smads immunostaining in 24 and 75 hpf wild-type animals.</title><p>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57603-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Quantification of p-Smads immunostaining in 24 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- embryos.</title><p>Related to <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57603-fig2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Evidence for p-Smad3 presence and function in OFT ECs at 24 hpf, but no evidence for p-Smad1/5/8 presence.</title><p>(<bold>A–B’</bold>) Confocal images showing <italic>Tg(12xSBE:</italic>EGFP) expression (white) in 24 (<bold>A</bold>) and 75 (<bold>B</bold>) hpf hearts. Green, ECs; white dotted lines outline the OFT. (<bold>C–D’</bold>) Confocal images of 75 hpf wild-type larvae immunostained for p-Smad3 (white, <bold>C</bold>) or showing <italic>Tg(12xSBE:</italic>EGFP) expression (white, <bold>D</bold>); white dotted lines outline the OFT; green dotted lines outline the ECs. (<bold>E</bold>) Schematics of a 36 hpf heart showing ECs inside (OFT ECs) and outside (heart ECs) the OFT quantified in <xref ref-type="fig" rid="fig2">Figure 2C</xref>. (<bold>F</bold>) Intensity ratio of p-Smad3 and p-Smad1/5/8 immunostaining (normalized to DAPI) between ECs and surrounding cells in the OFT at 24 hpf. Every dot represents the ratio of ECs vs surrounding cells in each embryo. (<bold>G–H’</bold>) 24 hpf <italic>Tg(kdrl:EGFP) alk5+/+</italic> (<bold>G</bold>) and <italic>alk5-/-</italic> (<bold>H</bold>) hearts immunostained for p-Smad1/5/8 (white). Dotted lines outline OFT ECs. (<bold>I</bold>) Quantification of p-Smad1/5/8 immunostaining (normalized to DAPI) in ECs and surrounding cells comparing 24 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- OFTs. (<bold>F, I</bold>) Plot values represent means ± SD; p values from <italic>t-</italic>tests. Scale bars: (<bold>A, A’, C–D’</bold>) 10 μm; (<bold>B, B’, G–H’</bold>) 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Next, we analyzed the effect of Alk5 loss on Smad3 signaling by performing p-Smad3 immunostaining on <italic>alk5+/+</italic> and <italic>alk5-/</italic>- embryos. As early as 24 hpf, that is, before the detection of a morphological defect, we observed a significant decrease in p-Smad3 immunostaining in <italic>alk5-/</italic>- OFTs in both ECs and surrounding cells (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>). To assess the requirement for Smad3 function downstream of Alk5 in the OFT, we treated <italic>alk5+/+</italic> and <italic>alk5-/</italic>- embryos with the Smad3 inhibitor SIS3 (<xref ref-type="bibr" rid="bib48">Jinnin et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Dogra et al., 2017</xref>) starting at 36 hpf and analyzed OFT morphology and function at 75 hpf (<xref ref-type="fig" rid="fig2">Figure 2G–K</xref>). Notably, Smad3 inhibition was sufficient to induce a mild OFT phenotype in <italic>alk5</italic> heterozygotes, also preventing the formation of the VA (<xref ref-type="fig" rid="fig2">Figure 2G,H</xref>), and to exacerbate the OFT defect of <italic>alk5-/</italic>- larvae (<xref ref-type="fig" rid="fig2">Figure 2I–K</xref>).</p><p>In addition, since Alk5 has been reported to stand at the cross-road between the TGF-β and BMP signaling pathways (<xref ref-type="bibr" rid="bib38">Grönroos et al., 2012</xref>; <xref ref-type="bibr" rid="bib44">Holtzhausen et al., 2014</xref>; <xref ref-type="bibr" rid="bib5">Aspalter et al., 2015</xref>), we also addressed the effect of Alk5 loss on BMP signaling by immunostaining embryos for p-Smad1/5/8 (the BMP-specific Smads). However, we did not observe preferential activation of Smad1/5/8 in the wild-type OFT endothelium (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>) or any significant differences between <italic>alk5+/+</italic> and <italic>alk5-/</italic>- embryos at 24 hpf (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G–I</xref>).</p><p>Collectively, these data indicate that Alk5 promotes Smad3 activation in the OFT endothelium, while it does not seem to affect the BMP signaling axis.</p></sec><sec id="s2-3"><title>Alk5 restricts EC proliferation in the cardiac OFT and promotes EC displacement toward the ventral aorta</title><p>Given the increased size of the mutant OFT, we first asked whether this phenotype was accompanied by an increase in cell number. In <italic>alk5+/+</italic> animals, the average number of OFT ECs increases from 21 cells at 36 hpf to 45 cells at 72 hpf (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref>). Consistent with the absence of a morphological phenotype, <italic>alk5-/</italic>- OFTs at 36 hpf were composed of an average of 22 ECs, similar to wild type (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, the number of ECs in the mutant OFT diverged substantially over time, and by 72 hpf twice as many ECs were observed in <italic>alk5</italic>-/- compared with wild type (85 ECs; <xref ref-type="fig" rid="fig3">Figure 3B</xref>). To investigate the underlying cause of this increase in cell number, we performed EdU labeling to assess EC proliferation. In the <italic>alk5-/</italic>- OFTs, we found that, by 36 hpf, ECs were already more likely to undergo cell cycle reentry than ECs in <italic>alk5+/+</italic> OFTs (<xref ref-type="fig" rid="fig3">Figure 3C–E</xref>). This abnormal increase in the number of EdU<sup>+</sup> ECs in <italic>alk5-/</italic>- OFTs became even more pronounced at later stages (48–72 hpf; <xref ref-type="fig" rid="fig3">Figure 3F–H</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Alk5 restricts EC proliferation in the cardiac OFT and is required for ventral aorta formation.</title><p>(<bold>A</bold>) Schematics of OFT ECs at 36 and 72 hpf. (<bold>B</bold>) Quantification of EC number (darker cells shown in A) in 36 and 72 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- OFTs (36 hpf: n = 11; 72 hpf: n = 6). (<bold>C–H</bold>) Confocal images (<bold>C, D, F, G</bold>) and quantification (<bold>E, H</bold>) of the percentage of EdU<sup>+</sup> ECs in <italic>Tg(kdrl:EGFP) alk5+/+</italic> and <italic>alk5-/</italic>- OFTs. Dotted lines outline the OFT; white dots mark EdU<sup>+</sup> ECs. All the other EdU<sup>+</sup> cells in the OFT region are <italic>kdrl:</italic>EGFP<italic><sup>-</sup></italic>. (<bold>I</bold>) Protocol used for photoconversion experiment. (<bold>J–K’</bold>) Confocal images of the OFT in 74 hpf <italic>Tg(fli1a:Kaede)</italic> larvae treated with DMSO or Alk5 inhibitor. Magenta, photoconverted ECs; dotted lines outline the OFT. (<bold>L</bold>) Quantification of the distance covered by photoconverted ECs between 54 and 72 hpf in DMSO and Alk5 inhibitor-treated larvae. (<bold>C, D, J–K’</bold>) Maximum intensity projections. (<bold>F, G</bold>) Single confocal planes. (<bold>B, E, H, L</bold>) Plot values represent means ± SD; p values from <italic>t</italic>-tests (<bold>E, H</bold>) or Mann Whitney (<bold>B, L</bold>). Scale bars: (<bold>C-G</bold>) 10 μm; (<bold>J–K’</bold>) 20 μm. See also <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Phenocopy of <italic>alk5</italic> mutants by Alk5 inhibitor treatment.</title><p>(<bold>A</bold>) Protocol used for Alk5 inhibitor treatments. (<bold>B–E</bold>) Confocal images of <italic>Tg(kdrl:EGFP)</italic> animals treated with DMSO or Alk5 inhibitor starting at 36 hpf and analyzed at 54 (<bold>B</bold>, n = 11; <bold>C</bold>, n = 11) or 78 (<bold>D</bold>, n = 13; <bold>E</bold>, n = 17) hpf. Asterisk, absence of the VA in Alk5 inhibitor-treated larvae. (<bold>F</bold>) Percentage of OFT expansion in 78 hpf control and Alk5 inhibitor-treated larvae; means ± SD; p value from <italic>t</italic>-test. For details about the quantifications, see Materials and methods ‘Defining the landmarks of the OFT’. (<bold>G</bold>) Schematics of the area photoconverted in H. (<bold>H, I</bold>) Confocal images of untreated photoconverted <italic>Tg(fli1a:Kaede)</italic> embryos at 54 (<bold>H</bold>, n = 5) and 74 (<bold>I</bold>, n = 5) hpf. (<bold>J</bold>) Schematics of the area photoconverted in K and L. (<bold>K, L</bold>) Confocal images of 54 hpf photoconverted <italic>Tg(fli1a:Kaede)</italic> DMSO (n = 9) or Alk5 inhibitor treated (n = 7) embryos. (<bold>H–L</bold>) Magenta, photoconverted ECs in the OFT (yellow arrowheads). (<bold>B–L</bold>) Dotted lines outline the OFT. (<bold>H, K, L</bold>) Single confocal planes. (<bold>B–E, I</bold>) Maximum intensity projections. AA1- 1° aortic arch, VA- ventral artery, BV- bulbo-ventricular canal. Scale bars: (<bold>B-E</bold>) 20 μm; (<bold>I–L</bold>) 10 μm; (<bold>H</bold>) 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig3-figsupp1-v1.tif"/></fig><media id="fig3video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig3-video1.mp4"><label>Figure 3—video 1.</label><caption><title>Time lapse-imaging of a <italic>Tg(fli1a:Kaede)</italic> fish treated with DMSO starting at 36 hpf and imaged from 56 to 74 hpf.</title><p>Magenta, photoconverted cell.</p></caption></media><media id="fig3video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig3-video2.mp4"><label>Figure 3—video 2.</label><caption><title>Time lapse-imaging of a <italic>Tg(fli1a:Kaede)</italic> fish treated with Alk5 inhibitor starting at 36 hpf and imaged from 56 to 74 hpf.</title><p>Magenta, photoconverted cell.</p></caption></media></fig-group><p>Together with an increased OFT size, <italic>alk5</italic> mutants also fail to form a VA. Therefore, we set out to investigate the behavior of ECs in the OFT and VA regions in embryos and larvae lacking Alk5 activity. We photoconverted OFT ECs in control and Alk5 inhibitor-treated larvae; treatment starting at 36 hpf with 2.5 μM of an Alk5-specific inhibitor caused increased OFT width at 54 and 78 hpf (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–F</xref>) as well as VA patterning defects (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D,E</xref>), thus phenocopying <italic>alk5</italic> mutants. Using this Alk5 inhibitor with the <italic>Tg(fli1a:Kaede)</italic> line, we aimed to track the photoconverted ECs in the region of the OFT. Since the population of ECs which gives rise to the VA was not previously characterized, we photoconverted ECs at 54 hpf in different regions of the OFT: the proximal region close to the bulbo-ventricular (BV) valve (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G,H</xref>), and the most distal region between the aortic arches (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1J,K</xref>). In wild-type fish, proximal ECs remained close to the photoconversion site up to 74 hpf (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H,I</xref>), whereas distal ECs were invariably found in the VA (<xref ref-type="fig" rid="fig3">Figure 3I–J’</xref>). In contrast, upon Alk5 inhibition, distal EC cells remained in the OFT (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1L</xref>, <xref ref-type="fig" rid="fig3">Figure 3K,K’</xref>). By 74 hpf, these distal ECs in Alk5 inhibitor treated larvae were found closer to the original photoconversion site compared with control larvae (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). To observe EC behavior at high resolution, we recorded time-lapse movies from 56 to 74 hpf following photoconversion (<xref ref-type="video" rid="fig3video1">Figure 3—videos 1</xref> and <xref ref-type="video" rid="fig3video2">2</xref>). While photoconverted ECs in control larvae extended rostrally and assumed an elongated shape (<xref ref-type="video" rid="fig3video1">Figure 3—video 1</xref>), suggesting their movement toward the VA, ECs in Alk5 inhibitor-treated larvae did not appear to move from their original position (<xref ref-type="video" rid="fig3video2">Figure 3—video 2</xref>).</p><p>Altogether, these data indicate that Alk5 plays a role in restricting EC proliferation in the OFT; it also promotes the formation of the ventral artery through a yet to be defined mechanism.</p></sec><sec id="s2-4"><title>Alk5 promotes the formation and stability of the OFT wall by regulating SMC proliferation and organization</title><p>During early larval stages, the OFT becomes covered by SMCs, which allow it to buffer the high blood pressure caused by ventricular contractions. In order to visualize SMCs, we used a pan-mural cell reporter line, <italic>Tg(pdgfrb:EGFP)</italic>, which labels pericytes and SMCs before they mature and start expressing established markers such as Acta2 (smooth muscle actin). We observed that the OFT endothelium in 75 hpf <italic>alk5+/+</italic> larvae is surrounded by an average of 90 ± 2 <italic>pdgfrb<sup>+</sup></italic> cells, organized in two to three compact layers with limited extracellular space (<xref ref-type="fig" rid="fig4">Figure 4A,A’, C</xref>). In contrast, <italic>alk5-/</italic>- larvae display a reduced number of <italic>pdgfrb<sup>+</sup></italic> SMCs (65 ± 2,–27%), wider extracellular space, and disorganized cell layers around the OFT (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>). The reduction in the total number of SMCs in <italic>alk5-/</italic>- OFTs is likely caused by a proliferation defect, as confirmed by EdU incorporation experiments performed at early larval stages (−53%; 48–72 hpf, <xref ref-type="fig" rid="fig4">Figure 4D</xref>). Furthermore, using TUNEL staining, we saw no evidence of SMC death by apoptosis (data not shown).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Alk5 regulates SMC and ECM organization in the cardiac OFT.</title><p>(<bold>A–C</bold>) Confocal images (<bold>A–B’</bold>) and quantification (<bold>C</bold>) of SMCs in 75 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larvae. Magenta, SMCs; white arrows, extracellular space between SMCs; boxed areas are shown in <bold>A’</bold> and <bold>B’</bold>; dotted lines outline the OFT. (<bold>D</bold>) Percentage of EdU<sup>+</sup> SMCs in 72 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larvae. (<bold>E–F’’</bold>) Confocal images of 75 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larvae immunostained for Elastin2 (Eln2). White arrowheads, SMCs devoid of Eln2; yellow arrowheads, SMCs surrounded by Eln2 immunostaining; boxed areas shown in <bold>E’, E’’, F’</bold> and <bold>F’’</bold>; images in <bold>E’</bold> and <bold>F’</bold> are shown with inverted colors; dotted lines outline the OFT. (<bold>G</bold>) Quantification of the percentage of SMCs surrounded by Eln2 immunostaining (per sagittal plane) at 75 hpf. (<bold>H–K</bold>) TEM images of 72 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- mutant OFTs at different magnifications (n = 3 for each genotype). Yellow, SMCs; red, cardiomyocytes close to the BV canal; asterisks, extracellular space; arrows, electron-dense (yellow) and double-membraned (red) vacuoles; dotted lines outline the OFT. (<bold>L–M’</bold>) Confocal images of <italic>alk5+/+</italic> (n = 5) and <italic>alk5</italic>-/- (n = 9) animals treated with LysoTracker, labeling lysosomes (small, circles; big, arrowheads); boxed areas are shown in <bold>L’</bold> and <bold>M’</bold>; dotted lines outline the OFT. (<bold>C, D, G</bold>) Plot values represent means ± SD; p values from <italic>t</italic>-tests. A- anterior, P- posterior, BV- bulbo-ventricular canal, CM- cardiomyocyte. Scale bars: , (<bold>A-I</bold>, <bold>L–M’</bold>) 10 μm; (<bold>J, K</bold>) 2 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig4-v1.tif"/></fig><p>In order to form a compact yet elastic wall, the SMCs are embedded within a specialized extracellular matrix (ECM), which provides essential biomechanical support as well as signaling cues to the SMCs (<xref ref-type="bibr" rid="bib86">Raines, 2000</xref>). To assess whether and how ECM structure and composition were affected in <italic>alk5</italic> mutants, we analyzed the localization of Elastin2 (Eln2; <xref ref-type="fig" rid="fig4">Figure 4E–G</xref>), a major ECM component in the OFT (<xref ref-type="bibr" rid="bib73">Miao et al., 2007</xref>). We observed that in <italic>alk5+/+</italic> larvae 77.4% of SMCs were surrounded by a continuous layer of Eln2, while in <italic>alk5-/</italic>- larvae only 35.8% were (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Moreover, in <italic>alk5-/</italic>- OFTs Eln2 localizes in small disrupted clusters, rather than in a bundle of elastic fibers as observed in <italic>alk5+/+</italic> (<xref ref-type="fig" rid="fig4">Figure 4E–F’’</xref>).</p><p>Next, we used transmission electron microscopy (TEM) to investigate OFT ultrastructure (<xref ref-type="fig" rid="fig4">Figure 4H–K</xref>). Even in a low-magnification view of <italic>alk5</italic>-/- OFTs, we could observe a greatly widened extracellular space surrounding the SMCs (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). At higher magnification, we observed that the ECM in wild-type larvae consisted mainly of thin layers (<xref ref-type="fig" rid="fig4">Figure 4J</xref>), while it consisted of broader electron-negative spaces in <italic>alk5</italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4K</xref>). Moreover, SMCs in the external layer of the mutant OFTs exhibited cytoplasmic inclusions (<xref ref-type="fig" rid="fig4">Figure 4I,K</xref>), such as electron-dense lysosomes (as confirmed by LysoTracker staining; <xref ref-type="fig" rid="fig4">Figure 4L–M’</xref>), and double-membraned vacuoles, resembling autophagosomes.</p><p>Overall, the loss of Alk5 function results in the formation of a defective SMC wall, including a structurally impaired ECM.</p></sec><sec id="s2-5"><title>Endothelial <italic>alk5</italic> overexpression is sufficient to restore cardiac OFT wall formation and function in <italic>alk5</italic> mutants</title><p>The earliest phenotype in <italic>alk5</italic> mutants is observed during the EC proliferation stages, therefore preceding the formation of the SMC wall. Thus, to investigate Alk5 requirement in the endothelium, we generated a transgenic line overexpressing <italic>alk5b</italic> specifically in ECs. We used the <italic>fli1a</italic> promoter to drive <italic>alk5b</italic> expression (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and validated the specificity of <italic>Tg(fli1a:alk5b-mScarlet)</italic> expression in endothelial and endocardial cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–A’’</xref>). We found that fish overexpressing <italic>alk5b</italic> in wild-type ECs reached adulthood, were fertile, and did not display obvious cardiovascular phenotypes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Notably, when <italic>alk5b</italic> was overexpressed specifically in ECs in <italic>alk5</italic> mutants, it was sufficient to restore cardiac function, as indicated by the lack of pericardial edema (<xref ref-type="fig" rid="fig5">Figure 5B,C</xref>). Indeed, <italic>alk5-/</italic>- larvae carrying the rescue transgene exhibited a wild-type morphology and function of the OFT and connecting vessels (<xref ref-type="fig" rid="fig5">Figure 5D–F</xref>), including a single VA and a wild-type like OFT expansion (<xref ref-type="fig" rid="fig5">Figure 5G</xref>; <xref ref-type="video" rid="fig5video1">Figure 5—video 1</xref>). Occasionally, the restored cardiac function and blood flow allowed a few (10.2%, n = 108) of the <italic>alk5</italic> rescued mutants to inflate their swim bladder and survive until 9 days post-fertilization (dpf) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B,C</xref>). However, despite the vascular rescue, the fish did not survive to adulthood, presumably due to the lack of Alk5 signaling in other tissues, as suggested by an altered morphology of the head (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>alk5</italic> endothelial-specific overexpression is sufficient to restore OFT wall formation and function in <italic>alk5</italic> mutants.</title><p>(<bold>A</bold>) Schematic of the construct used for endothelial-specific rescue experiments. (<bold>B, C</bold>) Brightfield images of 96 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larvae carrying the EC-specific <italic>alk5b</italic> rescue transgene (<italic>Tg</italic>). (<bold>D–F</bold>) Confocal images of the OFT in 72 hpf <italic>Tg(kdrl:EGFP)</italic> larvae, showing the morphological rescue in <italic>Tg(fli1a:alk5b-mScarlet) alk5</italic>-/- animals (<bold>F</bold>). Asterisk indicates the absence of the VA in <italic>alk5</italic> mutants; dotted lines outline the OFT. (<bold>G</bold>) Percentage of OFT expansion in 78 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, and <italic>Tg(fli1a:alk5b-mScarlet) alk5</italic>-/- animals. (<bold>H</bold>) Percentage of EdU<sup>+</sup> ECs in 72 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, and <italic>Tg(fli1a:alk5b-mScarlet) alk5</italic>-/- animals. (<bold>I–K</bold>) Confocal images of 75 hpf <italic>Tg(kdrl:EGFP)</italic> larvae immunostained for Eln2. Arrowheads, SMCs devoid of (white) or surrounded by (yellow) Eln2 immunostaining; <bold>I</bold>, n = 12; <bold>J</bold>, n = 13, <bold>K</bold>, n = 17. (<bold>G, H</bold>) Plot values represent means ± SD; p values from Kruskal-Wallis test, compared with the first column (<italic>alk5+/+)</italic>. VA- ventral artery; <italic>Tg- Tg(fli1a:alk5b-mScarlet).</italic> Scale bars: (<bold>B</bold>, <bold>C</bold>) 200 μm; (<bold>D–F, I–K</bold>) 10 μm. See also <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>alk5</italic> endothelial-specific overexpression is sufficient to restore OFT wall formation and function in <italic>alk5</italic> mutants.</title><p>(<bold>A–A’’</bold>) Ventral view of 120 hpf <italic>Tg(fli1a:alk5b-mScarlet) alk5+/+</italic> larvae, showing the restricted expression of the transgene in the ECs. Boxed area is shown in <bold>A’</bold> and <bold>A’’</bold>; dotted lines outline the OFT; arrowheads, SMCs. (<bold>B, C</bold>) Brightfield images of 9 dpf <italic>alk5+/+</italic> (<bold>B</bold>) and <italic>alk5-/</italic>- animals carrying the EC-specific rescue transgene (<italic>Tg,</italic> <bold>C</bold>) (11/108 <italic>alk5</italic> mutants analyzed inflated their swim bladder). Black arrowheads, swim bladder; pink arrowhead, deformation of the head. (<bold>D</bold>) Percentage of SMCs surrounded by Eln2 immunostaining (per sagittal plane) at 75 hpf. (<bold>E</bold>) Percentage of EdU<sup>+</sup> SMCs in 72 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, and <italic>Tg(fli1a:alk5b-mScarlet) alk5</italic>-/- animals. (<bold>D, E</bold>) Means ± SD; p value from Kruskal-Wallis tests, compared with the first column (<italic>alk5+/+</italic>). Scale bars: (<bold>A</bold>) 50 μm; (<bold>A’, A’’</bold>) 20 μm; (<bold>B, C</bold>) 200 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig5-figsupp1-v1.tif"/></fig><media id="fig5video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-57603-fig5-video1.mp4"><label>Figure 5—video 1.</label><caption><title>Confocal video of the beating heart of a <italic>Tg(kdrl:EGFP) alk5-/</italic>- larva at 78 hpf, carrying the <italic>fli1a:alk5b-mScarlet</italic> transgene and showing OFT expansion.</title></caption></media></fig-group><p>In order to analyze the EC-specific OFT rescue at a cellular level, we performed EdU incorporation experiments and observed that the number of proliferating ECs was reduced in transgenic <italic>alk5-/</italic>- larvae compared with <italic>alk5-/</italic>- not carrying the transgene (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Remarkably, the overexpression of <italic>alk5b</italic> in the endothelium of <italic>alk5</italic>-/- larvae also restored the formation of the SMC wall (<xref ref-type="fig" rid="fig5">Figure 5I–K</xref>). In fact, 75 hpf transgenic <italic>alk5-/</italic>- larvae exhibited SMCs organized in multiple layers around the OFT (<xref ref-type="fig" rid="fig5">Figure 5K</xref>), and 71.9% of these cells were surrounded by uniform Eln2 immunostaining (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>), a percentage similar to that observed in <italic>alk5+/+</italic> OFTs (77.6%). Moreover, the EC-specific overexpression of <italic>alk5b</italic> in <italic>alk5</italic> mutants was sufficient to restore SMC proliferation to wild-type levels (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>).</p><p>Overall, these data suggest that endothelial Alk5 signaling is sufficient to restore OFT morphology and function, including SMC wall formation, in <italic>alk5</italic> mutants.</p></sec><sec id="s2-6"><title>Alk5 signaling regulates ECM gene expression in the cardiac OFT</title><p>We hypothesized that Alk5 is required in the OFT and that it controls an expression program which modulates its structural integrity. To identify candidate effector genes, we performed a transcriptomic analysis using manually extracted 56 hpf hearts, including the OFTs, using control and Alk5 inhibitor-treated embryos (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). We chose 56 hpf as the developmental stage for this analysis in order to avoid secondary effects deriving from OFT malfunction.</p><p>Analysis of the Alk5 inhibitor-treated samples revealed 955 differentially expressed genes (DEGs), 480 of which were downregulated compared with control (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Notably, genes downregulated upon Alk5 inhibition encode multiple ECM components and the related Gene Ontology categories are amongst the most enriched (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B,C</xref>). In order to identify extracellular proteins that might function in signaling between ECs and SMCs, we compared the list of downregulated genes with the secreted factor genes from the zebrafish matrisome (<xref ref-type="bibr" rid="bib78">Nauroy et al., 2018</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). Amongst the 82 genes identified, five of them were specifically expressed in the OFT in adult zebrafish (<xref ref-type="bibr" rid="bib95">Singh et al., 2016</xref>). Thus, we analyzed the mRNA levels of these five genes by RT-qPCR and observed that they were also decreased in <italic>alk5-/</italic>- compared with <italic>alk5+/+</italic> larval hearts (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). Amongst the candidate genes, <italic>fbln5</italic> was one of the most downregulated in both <italic>alk5-/</italic>- and Alk5 inhibitor-treated larvae (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F</xref>). Importantly, we observed that <italic>fbln5</italic> expression is highly enriched in the OFT at 72 hpf (<xref ref-type="fig" rid="fig6">Figure 6A,B</xref>). Fbln5 is an ECM protein that mediates cell-to-matrix adhesion, and it has been reported to serve several functions including the inhibition of EC proliferation <italic>in vitro</italic> and the organization of the elastic lamina (<xref ref-type="bibr" rid="bib100">Sullivan et al., 2007</xref>; <xref ref-type="bibr" rid="bib116">Yanagisawa et al., 2009</xref>). Interestingly, mouse <italic>Fbln5</italic> is expressed in both fibroblasts/SMCs and ECs (<xref ref-type="bibr" rid="bib103">Tabula Muris Consortium et al., 2018</xref>), and also specifically in the embryonic OFT and aorta (<xref ref-type="bibr" rid="bib64">Liu et al., 2019</xref>). To confirm its expression in ECs in zebrafish embryos, we performed <italic>in situ</italic> hybridization at 36 hpf, a stage when SMCs are not yet covering the OFT. We detected <italic>fbln5</italic> expression in the OFT and in the first pair of aortic arches (<xref ref-type="fig" rid="fig6">Figure 6C,C’</xref>; <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A,A’</xref>), and we further detected its expression in OFT ECs (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B’, B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>fbln5</italic> endothelial-specific expression partially rescues the cardiac OFT defects in <italic>alk5</italic> mutants.</title><p>(<bold>A, B</bold>) Whole-mount <italic>in situ</italic> hybridization for <italic>fbln5</italic> expression in the OFT of 72 hpf <italic>alk5+/+</italic> (n = 13) and <italic>alk5</italic>-/- (n = 12) larvae. Dotted lines outline the OFT. (<bold>C, C’</bold>) Fluorescent <italic>in situ</italic> hybridization for <italic>fbln5</italic> expression (white) in the OFT of 36 hpf wild-type embryos. Green, ECs. Dotted lines outline the OFT, boxed area is shown in <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B,B’</xref>. (<bold>D–F</bold>) Confocal images of 85 hpf <italic>Tg(kdrl:dsRed) alk5+/+</italic> (n = 7)<italic>, alk5-/-</italic> (n = 9)<italic>, Tg(fli1:fbln5) alk5</italic>-/- (n = 9) larvae, showing the partial morphological rescue of the OFT and VA in <italic>Tg(fli1:fbln5) alk5</italic> -/- larvae (6/9, <bold>F</bold>). Asterisk indicates the absence of the VA in <italic>alk5</italic> mutants; dotted lines outline the OFT. (<bold>G</bold>) Percentage of OFT expansion in 78 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, and <italic>Tg(fli1:fbln5) alk5</italic>-/- animals. (<bold>H</bold>) Percentage of SMCs surrounded by Eln2 immunostaining (per sagittal plane) at 75 hpf. (<bold>I–K</bold>) Confocal images of 75 hpf larvae immunostained for Eln2. Yellow arrowheads, SMCs surrounded by Eln2 immunostaining; <bold>I</bold>, n = 7; <bold>J</bold>, n = 7; <bold>K</bold>, n = 11. (<bold>G, H</bold>) Plot values represent means ± SD; p values from Kruskal-Wallis tests, compared with the first column (<italic>alk5+/+)</italic>. AA- aortic arch, VA- ventral artery. Scale bars: (<bold>A</bold>, <bold>B</bold>) 50 μm; (<bold>C, C’, I–K</bold>) 10 μm; (<bold>D–F</bold>) 15 μm. See also <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplements 1</xref>–<xref ref-type="fig" rid="fig6s2">2</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Alk5 regulates the expression of ECM genes in the cardiac OFT, including that of <italic>fbln5.</italic></title><p>(<bold>A</bold>) Schematic showing the setting for the RNA-seq on extracted embryonic hearts (56 hpf). (<bold>B</bold>) Gene ontology bar plot, showing the most overrepresented cellular compartments up- or down-regulated in the Alk5 inhibitor-treated embryos compared with DMSO-treated ones. (<bold>C</bold>) Gene ontology bar plot, showing some of the most overrepresented biological processes downregulated in the Alk5 inhibitor-treated embryos compared to DMSO-treated ones. (<bold>D</bold>) Venn diagram depicting the genes downregulated (log2FC &lt; −0.585) in the Alk5 inhibitor-treated embryonic hearts, exclusively expressed in the adult zebrafish BA (<xref ref-type="bibr" rid="bib95">Singh et al., 2016</xref>), and part of the zebrafish matrisome (<xref ref-type="bibr" rid="bib78">Nauroy et al., 2018</xref>). The five genes in the intersection are listed in the box. (<bold>E</bold>) Relative mRNA levels of the five genes in the intersection obtained from 72 hpf <italic>alk5+/+</italic> and <italic>alk5-/</italic>- larval hearts. Means ± SD; p values from Mann Whitney tests; average Ct values are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. (<bold>F</bold>) MA plot displaying differentially expressed genes between Alk5 inhibitor-treated and control animals. <italic>fbln5</italic> is highlighted among the downregulated genes (red).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title><italic>fbln5</italic> is expressed in the cardiac outflow tract endothelium and its global overexpression partially rescues OFT defects in <italic>alk5</italic> mutants.</title><p>(<bold>A, A’</bold>) Whole-mount <italic>in situ</italic> hybridization for <italic>fbln5</italic> expression in the OFT of 36 hpf wild-type larvae (n = 6), combined with immunostaining for <italic>kdrl</italic>:EGFP (<bold>A’</bold>). Dotted lines outline the OFT, arrows point to regions with higher staining. (<bold>B, B’</bold>) Higher magnification of <xref ref-type="fig" rid="fig6">Figure 6C</xref>. Fluorescent <italic>in situ</italic> hybridization for <italic>fbln5</italic> expression (white) in the OFT of 36 hpf wild-type embryos. Green, ECs; arrows point to punctae of <italic>fbln5</italic> mRNA staining in ECs. (<bold>C</bold>) Relative mRNA levels of <italic>alk5b</italic> and <italic>fbln5</italic> in 72 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, and <italic>Tg(fli1a:alk5b-mScarlet) alk5</italic>-/- hearts. Average Ct values are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. (<bold>D</bold>) Percentage of OFT expansion in 78 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, and <italic>alk5-/</italic>- larvae injected with <italic>fbln5</italic> mRNA. (<bold>E</bold>) Percentage of EdU<sup>+</sup> ECs in 36 hpf <italic>Tg(kdrl:EGFP) alk5+/+</italic> and <italic>alk5-/</italic>- embryos following injection of <italic>fbln5</italic> mRNA. (<bold>F</bold>) Percentage of SMCs surrounded by Eln2 immunostaining (per sagittal plane) in 75 hpf <italic>alk5+/+</italic>, <italic>alk5-/-</italic>, <italic>Tg(fli1:fbln5) alk5</italic>-/-, and <italic>alk5-/</italic>- larvae injected with <italic>fbln5</italic> mRNA. (<bold>C–F</bold>) Plot values represent means ± SD; p values from Kruskal-Wallis (<bold>C, F</bold>) or one-way ANOVA (<bold>D, E</bold>) tests, compared with the first column (<italic>alk5+/+)</italic> unless otherwise stated (<bold>D</bold>). Scale bars: (<bold>A, A’</bold>) 20 μm; (<bold>B, B’</bold>) 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-fig6-figsupp2-v1.tif"/></fig></fig-group><p>The specific expression of <italic>fbln5</italic> in the developing OFT from early developmental stages and its downregulation in <italic>alk5</italic> mutants suggest a potential role for this ECM gene downstream of TGF-β signaling during OFT formation. To test this hypothesis, we analyzed <italic>fbln5</italic> expression in <italic>alk5-/</italic>- hearts when rescued with the endothelial <italic>fli1a:alk5b-mScarlet</italic> transgene. Notably, we observed an increase in <italic>fbln5</italic> mRNA levels by RT-qPCR in the rescued mutant hearts compared with mutant hearts not carrying the transgene, and the extent of this increase seemed to correlate with the level of <italic>alk5b</italic> expression in the rescued animals (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>). In order to assess a potential role for Fbln5 downstream of Alk5 in the OFT, we overexpressed <italic>fbln5</italic> globally by injecting <italic>fbln5</italic> mRNA into <italic>alk5</italic> mutants at the one-cell stage. Of note, this approach partially reduced the expansion of the OFT in <italic>alk5</italic>-/- animals, while it did not have an effect in wild types (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref>). To dig deeper into the potential role of Fbln5 downstream of Alk5 in ECs, we generated a transgenic line overexpressing <italic>fbln5</italic> in the endothelium (<italic>Tg(fli1a:fbln5)</italic>) in an <italic>alk5-/</italic>- background. Notably, the EC-specific overexpression of <italic>fbln5</italic> was sufficient to partially rescue OFT morphology and expansion in <italic>alk5-/</italic>- larvae (<xref ref-type="fig" rid="fig6">Figure 6D–G</xref>), as well as VA formation.</p><p>When analyzing the cell-specific defects, we observed that <italic>alk5</italic> mutants injected with <italic>fbln5</italic> mRNA exhibited a percentage of EdU<sup>+</sup> ECs (16.0%), comparable with wild types (15.6%) at early embryonic stages (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2E</xref>). Additionally, since <italic>fbln5</italic> has been shown to stabilize the elastic lamina in other contexts (<xref ref-type="bibr" rid="bib77">Nakamura et al., 2002</xref>; <xref ref-type="bibr" rid="bib14">Chapman et al., 2010</xref>), we aimed to assess its role specifically in organizing the OFT ECM. Importantly, EC-specific <italic>fbln5</italic> overexpression in <italic>alk5</italic> mutants led to a better organization of Eln2 immunostaining in the OFT, surrounding 58.5% of SMCs, compared with 31.1% in <italic>alk5-/</italic>- animals not carrying the transgene (<xref ref-type="fig" rid="fig6">Figure 6H–K</xref>). This level of rescue was also achieved by <italic>fbln5</italic> mRNA injections into one-cell stage embryos (56.4%; <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2F</xref>), suggesting that a great extent of the role of Fbln5 in the OFT can be carried out by its endothelial expression.</p><p>Overall, these data suggest that Fbln5 plays an important role in regulating the OFT ECM downstream of Alk5 signaling, leading to increased elastin organization and restricting EC proliferation.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Taking advantage of the zebrafish model, we report an important role for the TGF-β receptor I Alk5 in cardiac OFT morphogenesis. We show that TGF-β signaling through Alk5 restricts EC proliferation during early embryonic stages. Furthermore, loss of Alk5 causes defects in the SMC wall of the OFT. The combination of these phenotypes leads to defects in OFT structural integrity, eventually resulting in vessel dissection, reminiscent of human pathologies. Notably, restoring Alk5 expression in the endothelium is sufficient to rescue the OFT defects, suggesting a critical role for Alk5 in ECs.</p><sec id="s3-1"><title>Cell-specific role of Alk5 and TGF-β signaling in the cardiac OFT development</title><p>The TGF-β pathway’s multi-functional role results in many context- and tissue-dependent functions, which are difficult to unravel (<xref ref-type="bibr" rid="bib82">Pardali et al., 2010</xref>). Most studies on diseases of the great arteries have aimed to understand the role of TGF-β signaling in SMCs (<xref ref-type="bibr" rid="bib59">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib118">Yang et al., 2016</xref>; <xref ref-type="bibr" rid="bib120">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Perrucci et al., 2017</xref>; <xref ref-type="bibr" rid="bib104">Takeda et al., 2018</xref>), overlooking its function in the endothelium. In EC biology, Alk5 function has been mostly studied <italic>in vitro</italic>, where it has been shown to maintain EC quiescence (<xref ref-type="bibr" rid="bib32">Goumans et al., 2002</xref>; <xref ref-type="bibr" rid="bib33">Goumans et al., 2003</xref>; <xref ref-type="bibr" rid="bib57">Lebrin et al., 2004</xref>; <xref ref-type="bibr" rid="bib109">van Meeteren and ten Dijke, 2012</xref>; <xref ref-type="bibr" rid="bib68">Maring et al., 2016</xref>). In the zebrafish model, we confirmed a pivotal role for Alk5 in restricting EC proliferation <italic>in vivo</italic>. We found that ECs lacking Alk5 function also exhibited impaired movement in the OFT. Interestingly, <italic>alk5</italic> mutants fail to form the ventral aorta. Further studies will be needed to resolve the mechanisms responsible for VA formation and its impairment in <italic>alk5</italic> mutants. Moreover, it will be interesting to analyze in detail the aortic arch patterning in <italic>Alk5</italic>-/- mice, potentially unveiling defects in the connection between the OFT and the pharyngeal vessels.</p><p>Importantly, the early EC defects together with the endothelial-specific rescue data suggest that ECs are primarily responsible for the OFT phenotype in <italic>alk5-/</italic>- zebrafish. In fact, despite a broad <italic>alk5/</italic>Alk5 receptor expression in the zebrafish heart, the signaling appears to be initially enriched in the OFT endothelium. Similarly, while <italic>Alk5</italic> expression in mouse appears to be enriched in the aortic SMCs (<xref ref-type="bibr" rid="bib93">Seki et al., 2006</xref>), a few studies have suggested a pivotal role for TGF-β signaling in ECs (<xref ref-type="bibr" rid="bib96">Sridurongrit et al., 2008</xref>; <xref ref-type="bibr" rid="bib7">Bochenek et al., 2020</xref>). For example, although <italic>Tgfbr2</italic> deletion in SMCs leads to OFT expansion in mouse (<xref ref-type="bibr" rid="bib45">Jaffe et al., 2012</xref>), only EC-specific <italic>Alk5</italic> KO mice display the early cardiovascular defects of mice carrying a global <italic>Alk5</italic> mutation (<xref ref-type="bibr" rid="bib11">Carvalho et al., 2007</xref>; <xref ref-type="bibr" rid="bib96">Sridurongrit et al., 2008</xref>; <xref ref-type="bibr" rid="bib17">Dave et al., 2018</xref>). This discrepancy indicates distinct requirements for various TGF-β receptors in different cell types in the OFT, possibly at different developmental stages.</p><p>Remarkably, both mice and patients exhibiting aneurysms display a hyperactivation of downstream TGF-β signaling, despite carrying loss-of-function mutations in TGF-β genes (<xref ref-type="bibr" rid="bib49">Jones et al., 2009</xref>; <xref ref-type="bibr" rid="bib66">Mallat et al., 2017</xref>; <xref ref-type="bibr" rid="bib104">Takeda et al., 2018</xref>). In zebrafish <italic>alk5</italic> mutants, we initially observed a decrease in p-Smad3 signal before the appearance of the phenotype, and an exacerbation of the defect in <italic>alk5-/</italic>- embryos treated with a Smad3-specific inhibitor. In contrast, we then observed increased activation of the TGF-β pathway at later stages (75 hpf, data not shown), when –as in patients- the phenotype is already evident. These data suggest that the initial cause of the phenotype could arise from an early downregulation of the TGF-β pathway in ECs, providing new insights into a complex signaling event.</p></sec><sec id="s3-2"><title>Endothelium-smooth muscle interplay in the cardiac OFT and aorta</title><p>Surprisingly, we found that <italic>alk5</italic> overexpression in ECs was sufficient to restore SMC wall formation in <italic>alk5</italic> mutants. Although these results do not resolve whether ECs are the only cell type in which Alk5 is necessary for OFT morphogenesis, together with the initial activation of the TGF-β pathway in OFT ECs, they suggest that the SMC phenotype is a secondary effect from an endothelial defect. Perturbed interactions between ECs and SMCs have been implicated in different human pathologies including pulmonary hypertension, atherosclerosis and arteriovenous malformations (e.g. hereditary hemorrhagic telangiectasia) (<xref ref-type="bibr" rid="bib67">Mancini et al., 2009</xref>; <xref ref-type="bibr" rid="bib28">Gao et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Cunha et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Li et al., 2018</xref>).</p><p>The communication between ECs and SMCs can occur in different ways including via physical contact, exchange of signaling cues, and ECM deposition (<xref ref-type="bibr" rid="bib26">Gaengel et al., 2009</xref>; <xref ref-type="bibr" rid="bib62">Lilly, 2014</xref>; <xref ref-type="bibr" rid="bib60">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib102">Sweeney and Foldes, 2018</xref>), all of which are likely to play a role in the <italic>alk5</italic> mutant phenotype. In addition, during development, SMCs are recruited to the vessels once the initial establishment of the endothelial layer is complete (<xref ref-type="bibr" rid="bib98">Stratman et al., 2017</xref>; <xref ref-type="bibr" rid="bib102">Sweeney and Foldes, 2018</xref>). Thus, one can speculate that enhanced EC proliferation and remodeling in <italic>alk5</italic> mutants represent a less mature state of the vessel, thereby inhibiting SMC coverage of the OFT. Later on, reduced SMC coverage might further drive EC hyperproliferation in a positive feedback loop, contributing to the severity of the phenotype.</p><p>Overall, we suggest that the severe SMC phenotype causing the functional OFT defects and leading to aortic aneurysms in patients might be masking the important role of the endothelium in the early etiology of these pathologies. Therefore, it will be important to further characterize the role of ECs in SMC stabilization and vascular wall integrity.</p></sec><sec id="s3-3"><title>Identifying new molecular regulators of cardiac OFT development and disease</title><p>Analyses at several cellular and molecular levels provided insights into the structural changes directly linked to the functional phenotype in <italic>alk5</italic> mutants. Together with the observed defective elastic lamina and altered intercellular space, the transcriptomic data identified differential expression of several ECM component genes following inhibition of Alk5 function. The ECM is secreted by both ECs and SMCs and is a source of signaling mediators crucial for their interaction (<xref ref-type="bibr" rid="bib50">Kelleher et al., 2004</xref>; <xref ref-type="bibr" rid="bib19">Davis and Senger, 2005</xref>). One of the most promising ECM genes downregulated after Alk5 inhibition is <italic>fbln5,</italic> which encodes an integrin-binding extracellular protein (<xref ref-type="bibr" rid="bib76">Nakamura et al., 1999</xref>). In mouse, <italic>Fbln5</italic> is expressed, and its protein secreted, by both ECs and fibroblasts or SMCs (<xref ref-type="bibr" rid="bib76">Nakamura et al., 1999</xref>; <xref ref-type="bibr" rid="bib103">Tabula Muris Consortium et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Liu et al., 2019</xref>) and, in zebrafish, we found that it serves as a very specific marker for the OFT, starting from early developmental stages. Moreover, <italic>FBLN5</italic> expression has been shown to be directly induced by TGF-β signaling <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib1">Albig and Schiemann, 2004</xref>; <xref ref-type="bibr" rid="bib56">Kuang et al., 2006</xref>; <xref ref-type="bibr" rid="bib107">Topalovski et al., 2016</xref>). FBLN5 plays multiple functions such as assembling the elastic lamina surrounding SMCs (<xref ref-type="bibr" rid="bib77">Nakamura et al., 2002</xref>; <xref ref-type="bibr" rid="bib14">Chapman et al., 2010</xref>) and promoting EC-to-ECM attachment <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib85">Preis et al., 2006</xref>; <xref ref-type="bibr" rid="bib115">Williamson et al., 2007</xref>). The adhesion of ECs to the matrix, which is mediated in part by FBLN5, appears to be essential to restrict their proliferation, suggesting that FBLN5 functions as an anti-angiogenic factor (<xref ref-type="bibr" rid="bib1">Albig and Schiemann, 2004</xref>; <xref ref-type="bibr" rid="bib100">Sullivan et al., 2007</xref>). By enhancing the levels of <italic>fbln5</italic> in <italic>alk5</italic> mutants both globally and specifically in the endothelium, we were able to partially restore OFT morphology and function, as well as Eln2 coverage of SMCs. Although <italic>fbln5</italic> is expressed in both ECs and SMCs, its overexpression specifically in the endothelium seemed sufficient to ameliorate the <italic>alk5</italic> mutant phenotype. It is thus conceivable that ECs initiate the generation of a local extracellular environment around the OFT, which later is maintained and refined with the combined secretion of ECM components by both cell types.</p><p>Given the prevalence of OFT-related cardiovascular diseases, there is a need for multiple model systems that allow one to investigate the causes of these pathologies at the cellular and molecular levels, and the zebrafish could complement the mouse in this regard. Furthermore, the overlap of our transcriptomic data with the genes associated with aortic aneurysm (<xref ref-type="bibr" rid="bib8">Brownstein et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Kim and Stansfield, 2017</xref>), and the similarities between the endothelial ruptures in <italic>alk5</italic> mutants and those in human aortic dissection suggest that the zebrafish could serve as a valuable model for aneurysm research.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Danio rerio</italic>)</td><td><italic>Tg(kdrl:EGFP)s843</italic></td><td><xref ref-type="bibr" rid="bib47">Jin et al., 2005</xref></td><td>ZFIN: <italic>s843</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(kdrl:TagBFP)mu293</italic></td><td><xref ref-type="bibr" rid="bib70">Matsuoka et al., 2016</xref></td><td>ZFIN: <italic>mu293</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(kdrl:dsRed2)pd27</italic></td><td><xref ref-type="bibr" rid="bib52">Kikuchi et al., 2011</xref></td><td>ZFIN: <italic>pd27</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(fli1a:Gaf4ff)ubs4</italic></td><td><xref ref-type="bibr" rid="bib123">Zygmunt et al., 2011</xref></td><td>ZFIN: <italic>ubs4</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(UAS:Kaede)rk8</italic></td><td><xref ref-type="bibr" rid="bib43">Herwig et al., 2011</xref></td><td>ZFIN: <italic>rk8</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>TgBAC(pdgfrb:EGFP)ncv22</italic></td><td><xref ref-type="bibr" rid="bib4">Ando et al., 2016</xref></td><td>ZFIN: <italic>ncv22</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(kdrl:NLS-mCherry)is4</italic></td><td><xref ref-type="bibr" rid="bib114">Wang et al., 2010</xref></td><td>ZFIN: <italic>is4</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(12xSBE:EGFP)ia16</italic></td><td><xref ref-type="bibr" rid="bib12">Casari et al., 2014</xref></td><td>ZFIN: <italic>ia16</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>TgBAC(tgfbr1b:EGFP,cryaa:CFP)bns330</italic></td><td>This manuscript</td><td>ZFIN: <italic>bns330</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>Tg(fli1a:tgfbr1b-P2A-mScarlet-Hsa.HRAS)bns421</italic></td><td>This manuscript</td><td>ZFIN: <italic>bns421</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>tgfbr1a<sup>bns329</sup></italic></td><td>This manuscript</td><td>ZFIN: <italic>bns329</italic></td><td/></tr><tr><td>Genetic reagent (<italic>D. rerio</italic>)</td><td><italic>tgfbr1b<sup>bns225</sup></italic></td><td>This manuscript</td><td>ZFIN: <italic>bns225</italic></td><td/></tr><tr><td>Antibody</td><td>Anti-GFP (chicken polyclonal)</td><td>AvesLab</td><td>Cat#: GFP-1020</td><td>1:400</td></tr><tr><td>Antibody</td><td>Anti-Elastin2 (rabbit polyclonal)</td><td><xref ref-type="bibr" rid="bib73">Miao et al., 2007</xref></td><td/><td>1:100</td></tr><tr><td>Antibody</td><td>Anti-tRFP (rabbit polyclonal)</td><td>Evrogen</td><td>Cat# AB233</td><td>1:200</td></tr><tr><td>Antibody</td><td>Secondaries Alexa FluorTM 488-568-647 IgG (H+L) (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td/><td>1:500</td></tr><tr><td>Antibody</td><td>Anti-Smad3 (phospho S423 + S425) antibody (rabbit monoclonal)</td><td>Abcam</td><td>Cat# ab52903</td><td>1:100</td></tr><tr><td>Antibody</td><td>nti-phospho-Smad1/5 (Ser463/465)/Smad9 (Ser465/467) (rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>Cat# 13820</td><td>1:100</td></tr><tr><td>Antibody</td><td>Anti-dsRed (rabbit polyclonal)</td><td>Takara Bio Clontech</td><td>632496</td><td>1:200</td></tr><tr><td>Antibody</td><td>Anti-Alcama/Dm-Grasp (mouse monoclonal)</td><td>DSHB</td><td>ZN-8</td><td>1:50</td></tr><tr><td>Commercial assay or kit</td><td>Click-iT EdU Cell Proliferation Kit for Imaging, Alexa Fluor 647 dye</td><td>Thermo Fisher Scientific</td><td>Cat# C10340</td><td/></tr><tr><td>Commercial assay or kit</td><td>In-Fusion HD Cloning Plus</td><td>Takara Bio</td><td>Cat# 638910</td><td/></tr><tr><td>Commercial assay or kit</td><td>DyNAmo ColorFlash SYBR Green qPCR Mix</td><td>Thermo Scientific</td><td>Cat# F416S</td><td/></tr><tr><td>Chemical compound, drug</td><td>E-616452</td><td>Cayman Chemical</td><td>14794</td><td/></tr><tr><td>Chemical compound, drug</td><td>SIS3</td><td>Calbiochem/Merck</td><td>566405</td><td/></tr><tr><td>Chemical compound, drug</td><td>EdU</td><td>Thermo Fisher Scientific</td><td>Cat# A10044</td><td/></tr><tr><td>Chemical compound, drug</td><td>FITC-dextran 2000 kDa</td><td>Sigma</td><td>Cat# 52471</td><td/></tr><tr><td>Chemical compound, drug</td><td>LysoTracker Deep Red</td><td>Thermo <break/>Fisher Scientific</td><td>Cat# L12492</td><td/></tr><tr><td>Commercial assay or kit</td><td>miRNeasy micro Kit</td><td>Qiagen</td><td>Cat# 217084</td><td/></tr><tr><td>Commercial assay or kit</td><td>mMessage mMachine T3 Transcription Kit</td><td>Thermo Fisher Scientific</td><td>Cat# AM1348</td><td/></tr><tr><td>Commercial assay or kit</td><td>mMessage mMachine T7 Transcription Kit</td><td>Thermo Fisher Scientific</td><td>Cat# AM1344</td><td/></tr><tr><td>Commercial assay or kit</td><td>DIG RNA labeling kit</td><td>Roche</td><td>Cat# 11277073910</td><td/></tr><tr><td>Commercial assay or kit</td><td>Maxima First Strand cDNA kit</td><td>Thermo Fisher Scientific</td><td>Cat# K1641</td><td/></tr><tr><td>Commercial assay or kit</td><td>MegaShortScript T7</td><td>Thermo Fisher Scientific</td><td>Cat# AM1354</td><td/></tr><tr><td>Commercial assay or kit</td><td>RNA Clean and Concentrator Kit</td><td>Zymo Research</td><td>Cat# R1013</td><td/></tr><tr><td>Software, algorithm</td><td>ZEN Blue 2012</td><td>Zeiss, Germany</td><td/><td/></tr><tr><td>Software, algorithm</td><td>ZEN Black 2012</td><td>Zeiss, Germany</td><td/><td/></tr><tr><td>Software, algorithm</td><td>Imaris - Version 8.4.0</td><td>Bitplane, UK</td><td/><td/></tr><tr><td>Software, algorithm</td><td>GraphPad Prism 6</td><td>GraphPad Software, USA</td><td/><td/></tr><tr><td>Software, algorithm</td><td>FIJI/ImageJ</td><td><xref ref-type="bibr" rid="bib91">Schindelin et al., 2012</xref></td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish husbandry and lines</title><p>Larvae were raised under standard conditions. Adult fish were maintained in 3.5 l tanks at a stock density of 10 fish/l with the following parameters: water temperature: 27–27.5°C; light:dark cycle: 14:10; pH: 7.0–7.5; Conductivity: 750–800 µS/cm. Fish were fed three to five times a day, depending on age, with granular and live feed (<italic>Artemia salina</italic>). Health monitoring was performed at least once a year. Embryos were grown at 28°C and staged at 50–75% epiboly to determine synchronization.</p><p>The following lines were used in the study:</p><p><italic>Tg(kdrl:EGFP)s843</italic> (<xref ref-type="bibr" rid="bib47">Jin et al., 2005</xref>)<italic>; Tg(kdrl:TagBFP)mu293</italic> (<xref ref-type="bibr" rid="bib70">Matsuoka et al., 2016</xref>)<italic>; Tg(kdrl:dsRed2)pd27</italic> (<xref ref-type="bibr" rid="bib52">Kikuchi et al., 2011</xref>)<italic>; Tg(fli1a:Gaf4ff)ubs4</italic> (<xref ref-type="bibr" rid="bib123">Zygmunt et al., 2011</xref>) in combination with <italic>Tg(UAS:Kaede)rk8</italic> (<xref ref-type="bibr" rid="bib43">Herwig et al., 2011</xref>), abbreviated <italic>Tg(fli1a:Kaede</italic>); <italic>TgBAC(pdgfrb:EGFP)ncv22</italic> (<xref ref-type="bibr" rid="bib4">Ando et al., 2016</xref>), abbreviated <italic>Tg(pdgfrb:EGFP); Tg(12xSBE:EGFP)ia16</italic> (<xref ref-type="bibr" rid="bib12">Casari et al., 2014</xref>), <italic>Tg(kdrl:NLS-mCherry)is4</italic> (<xref ref-type="bibr" rid="bib114">Wang et al., 2010</xref>).</p></sec><sec id="s4-2"><title>Generation of transgenic lines</title><p>To generate <italic>TgBAC(tgfbr1b:EGFP,cryaa:CFP)bns330</italic>, abbreviated <italic>TgBAC(alk5b:EGFP)</italic>, we used the BAC clone CH1073-59L16 (BACPAC Resources Center), containing 37.3 kb of the <italic>tgfbr1b</italic> locus. All recombineering steps were performed as previously described (<xref ref-type="bibr" rid="bib10">Bussmann and Schulte-Merker, 2011</xref>), except for the addition of a cryaa:CFP-iTol2 cassette to identify transgenic animals. In addition, we removed the kanamycin-resistance cassette in the last step, taking advantage of Flippase recombination. The following homology arms were used to amplify and recombine the EGFP_Kan cassette: <italic>alk5b</italic> HA1 GFP fw 5’- <named-content content-type="sequence">ACTGGAGTCCAGCAGGAGAACAGAAGAGGAGCGGGATTATCTCCAGGAGGACCATGGTGAGCAAGGGCGAGGAG</named-content>-3’, <italic>alk5b</italic> HA2 Kan rv 5’- <named-content content-type="sequence">ACCAGTCGACACGGCACTGCCTCCATCATCATCATCTTCATCATCATCTTTTCCAGAAGTAGTGAGGAG</named-content> −3’. The following homology arms were used to amplify and recombine the cryaa:CFP_iTol2 cassette: Fosmid iTol2_eye fw: 5’-<named-content content-type="sequence">TTCTCTGTTTTTGTCCGTGGAATGAACAATGGAAGTCCGAGCTCATCGCTCCCTGCTCGAGCCGGGCCCAAGTG</named-content> −3’; Fosmid iTol2_eye rv: 5’- <named-content content-type="sequence">AGCCCCGACACCCGCCAACACCCGCTGACGCGAACCCCTTGCGGCCGCATGAAACAGCTATGACCATGTAA</named-content>-3’.</p><p>To generate <italic>Tg(fli1a:tgfbr1b-P2A-mScarlet-Hsa.HRAS)bns421</italic>, abbreviated <italic>Tg(fli1a:alk5b-mScarlet),</italic> the full-length <italic>tgfbr1b</italic> (NM_001115059) coding sequence was amplified using the primers <italic>alk5b</italic> ATG fw 5’- <named-content content-type="sequence">GGATGAAGATGATGATGAAGATG</named-content> −3’ and <italic>alk5b</italic> noSTOP rev 5’- <named-content content-type="sequence">CATCTTGATTCCCTCCTGct</named-content> −3’. <italic>alk5b</italic> was cloned downstream of the <italic>fli1a</italic> enhancer-promoter sequence (<italic>fli1ep)</italic> (<xref ref-type="bibr" rid="bib111">Villefranc et al., 2007</xref>), into a plasmid containing the P2A sequence (<xref ref-type="bibr" rid="bib53">Kim et al., 2011</xref>) and the mScarlet coding sequence, fused with Hsa.HRAS human sequence for membrane localization. The <italic>fli1ep</italic> sequence was amplified with the following primers: <italic>fli1a fw</italic> 5’-<named-content content-type="sequence">TTGGAGATCTCATCTTTGAC</named-content>-3’, <italic>fli1a rev</italic> 5’-<named-content content-type="sequence">GGTGGCGCTAGCTTCGCGTCTGAATTAATTCC</named-content>-3’.</p><p>To generate <italic>Tg(fli1a:fbln5,EGFP)</italic>, abbreviated <italic>Tg(fli1a:fbln5),</italic> the full-length <italic>fbln5</italic> (NM_001005979) coding sequence was amplified by wild-type cDNA with the following primers <italic>fbln5</italic> ATG fw 5’-<named-content content-type="sequence">ATGTTTGTTGAACTACGTGGC</named-content>-3’, <italic>fbln5</italic> STOP rv 5’-<named-content content-type="sequence">TCAGAATGGATGTTCGGAGAC</named-content>-3’. The <italic>fbln5</italic> CDS was cloned in the <italic>fli1aep:EGFP,mCherry</italic> (<xref ref-type="bibr" rid="bib80">Nicoli et al., 2010</xref>) substituting the mCherry CDS. The experiments were conducted on F1 embryos and larvae deriving from the same F0 founder.</p><p>All cloning experiments, except for the BAC, were performed using InFusion Cloning. All vectors had <italic>Tol2</italic> elements to facilitate genome integration.</p></sec><sec id="s4-3"><title>Generation of mutant lines using CRISPR/Cas9 technology</title><p>In order to generate <italic>tgfbr1a<sup>bns329</sup></italic> (referred to as <italic>alk5a</italic> mutants) and <italic>tgfbr1b<sup>bns225</sup></italic> (referred to as <italic>alk5b</italic> mutants) mutant lines, a CRISPR design tool (<ext-link ext-link-type="uri" xlink:href="https://chopchop.cbu.uib.no/">https://chopchop.cbu.uib.no/</ext-link>) was used to design sgRNAs. For <italic>tgfbr1a <sup>bns329</sup></italic>, a sgRNA targeting exon 1 (targeting sequence: <named-content content-type="sequence">GGATGATCTTTACCCCC</named-content>) and for <italic>tgfbr1b<sup>bns225</sup>,</italic> a sgRNA targeting exon 4 (targeting sequence: <named-content content-type="sequence">GAGGAGCGCTCCTGGTTC</named-content>) were assembled as described previously (<xref ref-type="bibr" rid="bib27">Gagnon et al., 2014</xref>; <xref ref-type="bibr" rid="bib110">Varshney et al., 2015</xref>). Briefly, sgRNAs and <italic>Cas9</italic> mRNA were transcribed <italic>in vitro</italic> with a MegaShortScript T7 Transcription Kit and an mMESSAGE mMACHINE T3 Transcription Kit, respectively, and purified with RNA Clean and Concentrator Kit. To synthesize <italic>Cas9</italic> mRNA, pT3TS-nCas9n (Addgene) was used as a template. 50 pg sgRNA and 300 pg <italic>Cas9</italic> mRNA were injected into 1 cell stage embryos. The mutants were genotyped using high-resolution melt analysis (HRMA) (Eco-Illumina) with the following primers: <italic>alk5a</italic> HRM fw: 5’- <named-content content-type="sequence">CTTCTGGACAGACCGTGACA</named-content>-3’, <italic>alk5a</italic> HRM rv: 5’- <named-content content-type="sequence">GAAGGAGCGCACTGGAAAG</named-content> −3’, <italic>alk5b</italic> HRM fw: 5’- <named-content content-type="sequence">CGCTGGAGAGGAGAGGAGG</named-content> −3’, <italic>alk5b</italic> HRM rv: 5’- <named-content content-type="sequence">GTCTCAGCATGACGGTCTGG</named-content> −3’, and/or by sequencing; <italic>alk5</italic> mutants carrying the <italic>Tg(fli1a:alk5b-mScarlet)</italic> transgene were genotyped by HRMA with the following primers, in order to amplify exclusively the genomic locus: <italic>alk5b</italic> HRM rescue fw: 5’- <named-content content-type="sequence">AGAGGAGAGGAGGTGGCG</named-content>-3’, <italic>alk5b</italic> HRM intron rv: 5’- <named-content content-type="sequence">CCCATGATGCCCCAGTGC</named-content> −3’.</p><p>The <italic>tgfbr1a <sup>bns329</sup></italic> fish carry a 2 bp insertion and a 6 bp deletion in exon 1, while the <italic>tgfbr1b<sup>bns225</sup></italic> fish carry a 3 bp insertion and an 11 bp deletion in exon 4. <italic>alk5a+/-; alk5b+/-</italic> fish were incrossed to obtain <italic>alk5a-/-;alk5b+/-</italic> and <italic>alk5a+/+;alk5b+/+</italic> adults. For the majority of the experiments, <italic>alk5-/-</italic> (<italic>alk5a-/-;alk5b-/-</italic>) embryos and larvae were obtained from <italic>alk5a-/-;alk5b+/-</italic> parents, while <italic>alk5+/+</italic> embryos and larvae were obtained from <italic>alk5a+/+;alk5b+/+</italic> parents; thus<italic>, alk5-/- and alk5+/+</italic> animals were first generation cousins. Larvae analyzed in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1M</xref> and <xref ref-type="fig" rid="fig4">Figure 4A–C</xref> were obtained from <italic>alk5a+/-; alk5b+/-</italic> parents; thus, <italic>alk5+/+ and alk5-/</italic>- animals are siblings.</p><p>Injection of <italic>fbln5</italic> mRNA <italic>fbln5</italic> (NM_001005979) complete coding sequence was amplified by wild-type cDNA with the following primers <italic>fbln5</italic> ATG fw 5’-<named-content content-type="sequence">ATGTTTGTTGAACTACGTGGC</named-content>-3’, <italic>fbln5</italic> STOP rv 5’-<named-content content-type="sequence">TCAGAATGGATGTTCGGAGAC</named-content>-3’ and cloned into the pCS2<sup>+</sup> plasmid. The mRNA was synthesized <italic>in vitro</italic> using the mMESSAGE mMACHINE T7 Transcription Kit and purified with RNA Clean and Concentrator. 150 pg of <italic>fbln5</italic> mRNA was injected into one-cell stage embryos deriving from <italic>alk5a-/-; alk5b+/-</italic> and <italic>alk5+/+</italic> crosses, and non-injected embryos deriving from the same crosses were used as controls.</p></sec><sec id="s4-4"><title>Dextran injections</title><p>Larvae at 96 hpf were embedded in low-melting agarose containing 0.01% Tricaine (Sigma) and positioned on their side. They were injected with 2 nl of fluorescein isothiocyanate (FITC)-dextran 2000 kDa in the portion of the posterior cardinal vein on top of the yolk elongation. After verifying the correct injection on a Nikon SMZ25 stereomicroscope, larvae were recovered for 10 min in egg water and then embedded in 1% low melting agarose containing 0.2% tricaine. The larvae were then imaged with a confocal microscope and subsequently genotyped.</p></sec><sec id="s4-5"><title>Chemical treatments</title><p>The Alk5 inhibitor II, E-616452 (<xref ref-type="bibr" rid="bib30">Gellibert et al., 2004</xref>), was dissolved in DMSO to create a stock solution (10 mM) and frozen in aliquots for single use. Embryos were treated with the inhibitor, at a final concentration of 2.5 μM (diluted in egg water), starting at 36 hpf until the desired stage for analysis. Different concentrations were previously tested to minimize off-target developmental defects and, for the desired stage, 2.5 μM appeared to be the lowest effective dose. Control embryos were treated for the same time with 0.025% DMSO.</p><p>For Smad3 inhibitor experiments, SIS3 (<xref ref-type="bibr" rid="bib48">Jinnin et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Dogra et al., 2017</xref>) was dissolved in DMSO to create a 5 mM stock solution and frozen in aliquots for single use. Embryos were treated with the inhibitor, at a final concentration of 1.5 μM (diluted in egg water), or DMSO from 36 hpf until 75 hpf, protected from light.</p><p>For LysoTracker experiments, 95 hpf larvae were incubated at 28°C for 1 hr in egg water containing 10 μM LysoTracker Deep Red (Thermo Fisher Scientific) and rinsed several times with fresh water before imaging by confocal microscopy.</p></sec><sec id="s4-6"><title>Whole mount immunostaining</title><p>Whole mount immunostaining was performed as described previously (<xref ref-type="bibr" rid="bib39">Gunawan et al., 2019</xref>), with some modifications. Briefly, embryos or larvae were fixed in 4% PFA after stopping the heart with 0.2% Tricaine to prevent the collapse of the tissues during fixation. Embryos were then washed and deyolked using forceps. The blocking step was performed in PBS/1% BSA/1%DMSO/0.5% Triton X-100 (PBDT) and 5% goat serum. Primary and secondary antibody incubations were performed overnight at 4°C. Embryos were incubated with 1 µg/ml DAPI during secondary antibody incubation.</p><p>Primary antibodies used were GFP (1:400), Elastin2 (1:100), tRFP (1:200), anti-dsRed (1:200), anti-Alcama/Dm-Grasp (1:50), anti-p-Smad3 (1:100) and anti-pSmad1/5/8 (1:100). Secondary antibodies were used at 1:500 concentration.</p><p>Elastin2 antibody was purified from the previously described serum stock (<xref ref-type="bibr" rid="bib73">Miao et al., 2007</xref>). For all the immunostainings, animals were genotyped after the required image analyses.</p></sec><sec id="s4-7"><title>Whole mount <italic>in situ</italic> hybridization</title><p>The following primers were used to generate the DNA template for <italic>in situ</italic> RNA probes: <italic>alk5b</italic> ISH fw: 5’- <named-content content-type="sequence">TCATGAGCACGGTTCTCTG</named-content><named-content content-type="sequence">T</named-content> - 3’, <italic>alk5b</italic> ISH T7 rv: 5’- <named-content content-type="sequence">GTAATACGACTCACTATAGGATCCCCAATGAGTCGGTGTT</named-content> - 3’, <italic>fbln5</italic> ISH fw: 5’- <named-content content-type="sequence">TGTTCTCACAGGTTCTTGCC</named-content>- 3’, <italic>fbln5</italic> ISH T7 rv: 5’- <named-content content-type="sequence">TAATACGACTCACTATAGGGCAGGGCTACAGGAACAGGAA</named-content>- 3’.</p><p>Digoxigenin (DIG)-labeled probes were transcribed <italic>in vitro</italic>, with T7 polymerase (Promega) and DIG RNA labeling kit (Roche), using as template the PCR amplicon. Larvae were then collected at the desired stage and fixed with 4% PFA overnight at 4°C. <italic>In situ</italic> hybridization was performed as described previously (<xref ref-type="bibr" rid="bib105">Thisse and Thisse, 2008</xref>). For <xref ref-type="fig" rid="fig6">Figure 6A,B</xref> and <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A,A’</xref>, anti-GFP primary antibody (1:300 dilution) labeling the endothelium of <italic>Tg(kdrl:EGFP)</italic> larvae was added together with the anti-Dig antibody. The secondary antibody anti-chicken Alexa Fluor 488 (Thermo Fisher Scientific) was added after BM Purple treatment, for 2 hr at room temperature, and followed by PBS/Tween 0.1% (PBST) washes before imaging. For fluorescent <italic>in situ</italic> hybridization, the same protocol of the whole mount bright-field <italic>in situ</italic> was conducted with the following modifications. During the first day, embryos were incubated in 1% H<sub>2</sub>O<sub>2</sub> for 30 min. During the second day, after the blocking step, embryos were incubated with the primary antibodies anti-DIG-POD (Roche, 1:500) and anti-dsRed (1:200). The next day, after six washes in PBST, embryos were incubated with Amplification solution (TSA fluorescein detection kit) for 2 min. FITC (1:100) was added to the Amplification solution to develop the signal. The embryos were then incubated in the mix for 30 min in the dark at RT and washed in PBST. Embryos were then incubated 2 hr with secondary antibody solution (goat anti-rabbit 568, 1:500) and 1 µg/ml DAPI, and then extensively washed in PBST before imaging.</p><p>Embryos were imaged on a Nikon SMZ25 stereomicroscope with a 2×/0.3 objective or LSM700 Axio Imager 40x objective and, if necessary, genotyped afterward.</p></sec><sec id="s4-8"><title>EdU assays</title><p>Embryos were incubated in egg water containing 0.5 mM EdU/0.5% DMSO (12 animals/4 ml in 6-well plates). Embryos were treated from 24 to 36 hpf or 48 to 72 hpf, according to the experiment, followed by fixation and whole-mount immunostaining, with anti-GFP, anti-Eln2, and DAPI, as described above. The Click-iT reaction was performed after the incubation with the secondary antibody, following the Click-iT EdU Cell Proliferation Kit for Imaging, Alexa Fluor 647 dye manufacturer protocol.</p><p>The percentage of EdU<sup>+</sup> ECs was calculated with the following formula: % EdU<sup>+</sup> cells = (number of DAPI<sup>+</sup>GFP<sup>+</sup> EdU<sup>+</sup> cells/total number of DAPI<sup>+</sup>GFP<sup>+</sup> cells in the (OFT) x 100). Differently, for <xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>, the percentage of EdU<sup>+</sup> cells refers to the number of DAPI<sup>+</sup>GFP<sup>-</sup> cells (SMCs) in the region of the OFT.</p><p>As we observed different percentages of labeled cells depending on the batch of EdU, all the replicates and internal controls for each experiment were performed using the same batch of EdU.</p></sec><sec id="s4-9"><title>Confocal microscopy imaging</title><p>For live confocal imaging, embryos or larvae were embedded in 1% low-melting agarose/egg water with 0.2% or 0.01% tricaine to image stopped or beating hearts, respectively. Fixed embryos were mounted in 1% low-melting agarose/egg water without tricaine. All embryos or larvae were imaged with LSM700 Axio Imager, LSM800 Axio Examiner or LSM880 Axio Examiner confocal microscope with a W Plan-Apochromat 40×/1.0 or W Plan-Apochromat 20×/1.0 dipping lenses, unless otherwise stated. In order to image the heart region, embryos from 54 hpf onwards were imaged in ventral view. In <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–B’, M</xref>, embryos were mounted on their side to visualize the trunk.</p><p>Embryos at 36 hpf were fixed with 4% PFA overnight at 4°C. Embryos were then washed with PBS/0.1% Tween20. The yolk and most of the yolk sac of the embryos were then removed using forceps. Before mounting, the trunk was removed and the heads of the embryos were mounted with the ventral side toward the objective. Therefore, the images were taken accessing to the heart from the region where the yolk was previously located. The same mounting strategy was used to image all the embryos at 36 hpf after EdU assays.</p><p>To realize videos of beating hearts, fish were mounted in 0.8% low-melting agarose/egg water, containing 0.01% tricaine or without tricaine for heart rate measurements. Videos were acquired with an exposure time of 10 ms, at 100 frames/s for 150 frames, covering approximately 3–4 heartbeats; for heart rate measurements, videos were acquired with 5 ms exposure for 5000 frames (approximately 30 s). Videos were acquired with an LD C-Apochromat 40×/1.1 water immersion lens (Zeiss Cell Observer spinning disk microscope with a CSU-X1 scanner unit [Yokogawa] and Hamamatsu ORCAflash4.0 sCMOS cameras).</p><p>Time-lapse videos were acquired with LSM800 Axio Observer microscope with Plan-Apochromat 20X/0.8. Embryos were mounted in 0.8% low-melting agarose/egg water with 0.01% tricaine in four-well Chambered Coverglass (Thermo Fisher Scientific) and covered with egg-water containing DMSO or Alk5 inhibitor solution, as described above. Stacks of the OFT and connecting vessels were acquired every 45 min for 24 cycles (18 hr) starting from 56 hpf, after the photoconversion. Only fish that survived until the end of the time-lapse were subsequently analyzed.</p><p>All images were acquired using the Zeiss ZEN program.</p></sec><sec id="s4-10"><title>Photoconversion</title><p><italic>Tg(fli1a:GAL4FF); Tg(UAS:Kaede)</italic> (<xref ref-type="bibr" rid="bib42">Hatta et al., 2006</xref>) embryos were treated with Alk5 inhibitor or DMSO as described above and embedded in 1% low-melt agarose with 0.2% tricaine at 54 hpf. Photoconversion was performed on a LSM880 Axio Examiner confocal microscope with a W Plan-Apochromat 20×/1.0 dipping lens. Embryos, mounted ventrally to expose the OFT, were first imaged with 488 and 561 nm lasers to establish a region of interest (ROI) and verify the absence of red signal before photoconversion. The ROI was photoconverted with three scans (4.5 s) of the 405 nm laser. Then, another scan with only 488 and 561 nm lasers was performed to verify the efficiency of the photoconversion. Embryos were quickly removed from the agarose, incubated at 28°C in separate wells of a 24-well plate in the dark to recover the heartbeat. According to the experiment, embryos were kept in the incubator until 56 or 74 hpf. 74 hpf larvae (<xref ref-type="fig" rid="fig3">Figure 3J–K’</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I</xref>) were imaged with an LSM880 Axio Examiner to locate the photoconverted cells, while 56 hpf embryos were imaged overnight with time-lapses as described above (<xref ref-type="video" rid="fig3video1">Figure 3—videos 1</xref> and <xref ref-type="video" rid="fig3video2">2</xref>).</p></sec><sec id="s4-11"><title>Defining landmarks for OFT analyses</title><p>Since markers to label the zebrafish OFT are currently lacking, we defined it using anatomical features, similar to what was previously described (<xref ref-type="bibr" rid="bib94">Sidhwani et al., 2019</xref>). The proximal boundary was defined by the point of endocardium and myocardium constriction between the ventricle and the OFT. From 54 hpf onwards for the photoconversion experiments, this constriction in the endocardium has also been named the bulbo-ventricular (BV) canal, since it represents the region where the BV valve will form. The distal boundary was determined, up to 56 hpf, by the point of bifurcation of the OFT endocardium toward the first aortic arch pair (AA1). From 72 hpf onwards, the distal boundary was determined by the constriction of the OFT endocardium at the opening of the VA.</p><p>OFT width was assessed at 36 and 54 hpf on the 3D reconstructions obtained with Imaris (Bitplane), and the diameter in the region of maximum BV constriction was determined (orange line in the figures). At 78 hpf, OFT expansion was measured in beating heart movies with the FiJi ImageJ software (<xref ref-type="bibr" rid="bib91">Schindelin et al., 2012</xref>), in an average of 3–4 heartbeats per larva, with the following formula: OFT expansion (%) = [(maximum OFT area (during ventricular systole) - minimum OFT area (during ventricular diastole))/minimum OFT area] x 100.</p></sec><sec id="s4-12"><title>Dorsal aorta diameter measurement</title><p>Animals at 56 and 96 hpf were mounted on their side in 1% low-melting agarose as described above and imaged with an LSM700 Axio Imager with an LD LCI Plan-Apochromat 25×/0.8 lens. After the imaging at 56 hpf, the embryos were kept separately in 48-well plates until 96 hpf. After the second imaging at 96 hpf, the gDNA of individual fish was extracted, and the fish were genotyped after performing the measurements. The dorsal aorta diameter was measured after creating a maximum intensity projection of the images with the ZEN software. The diameter plotted is an average of four measurements performed in different regions of the dorsal aorta, comprised within the 10 somites above the yolk extension.</p></sec><sec id="s4-13"><title>Data analysis and quantification</title><p>To count ECs in <xref ref-type="fig" rid="fig3">Figure 3B</xref> and SMCs in <xref ref-type="fig" rid="fig4">Figure 4C</xref>, <italic>Tg(kdrl:EGFP)</italic> and <italic>TgBAC(pdgfrb:EGFP)</italic>; <italic>Tg(kdrl:TagBFP)</italic> embryos and larvae, respectively, were fixed at 36, 72 or 75 hpf. The animals were then immunostained with anti-GFP and/or anti-tRFP antibodies and DAPI as described above. To count ECs, DAPI<sup>+</sup>GFP<sup>+</sup> cells were counted in the OFT region highlighted in <xref ref-type="fig" rid="fig3">Figure 3A</xref>. To count SMCs, DAPI<sup>+</sup>GFP<sup>+</sup> BFP<sup>-</sup> cells were counted in the OFT region. EC and SMC cell counting was performed with Imaris (Bitplane).</p><p>The quantification of the displacement length of photoconverted cells between 54 and 74 hpf was performed with Imaris (Bitplane) (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). The distance of the photoconverted Kaede Red<sup>+</sup> cell from the bulbo-ventricular (BV) valve at 54 hpf was measured and then subtracted from the distance of the Kaede Red<sup>+</sup> cell farthest from the BV valve at 74 hpf.</p><p>For the quantification of Eln2<sup>+</sup> cells around the OFT, Eln2<sup>+</sup> DAPI<sup>+</sup> GFP<sup>-</sup> cells were counted. Quantification was started at the OFT mid-sagittal plane and cells were counted in two planes up and two down from that plane, at an increment of 2 μm per plane. An average of these five planes was used for the analyses. The percentage of Eln2<sup>+</sup> cells was calculated as (Eln2<sup>+</sup> DAPI<sup>+</sup> GFP<sup>-</sup> cells)/(DAPI<sup>+</sup> GFP<sup>-</sup> cells).</p><p>For quantification of p-Smad immunostaining, mean grey values of p-Smads and DAPI stainings were calculated with Fiji in at least seven cells from at least three single optical slices per embryo/larva. The cells analyzed were randomly chosen based on the DAPI signal, and ECs (or surrounding cells) were selected based on the <italic>kdrl:</italic>EGFP signal. Subsequently, p-Smad/DAPI ratios were generated for each cell, and the average of all the cells for each embryo was calculated. In <xref ref-type="fig" rid="fig2">Figure 2B,C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>, the average of pSmad/DAPI normalized grey values was compared between different cells in the same embryo (ECs vs surrounding cells or OFT ECs vs heart ECs). The ratios obtained for each embryo were plotted in the graphs.</p><p>All statistical analyses were performed in GraphPad Prism (Version 6.07) and parametric <italic>t</italic>-tests or non-parametric Mann Whitney tests were performed after assessing the normal distribution of the data with D’Agostino-Pearson normality test. For multiple comparisons, one-way ANOVA, followed by Tukey’s post-hoc test, or non-parametric Kruskal-Wallis test, followed by Dunn’s post-hoc test, were performed. Illustrations were done in Inkscape (XQuartz X11).</p></sec><sec id="s4-14"><title>Randomization and blinding procedures</title><p>For all the experiments using <italic>alk5</italic> mutants, animals of different genotypes were collected, processed in the same dish (or tube) and genotyped after the imaging and analysis.</p><p>For all the experiments using Alk5 inhibitor, embryos deriving from <italic>Tg(kdrl:EGFP)</italic> outcrosses were collected. Afterwards, the embryos from the same batch were divided into two groups (treated and controls).</p><p>The investigators were blinded to allocation during experiments and outcome assessment, whenever possible.</p></sec><sec id="s4-15"><title>Transmission electron microscopy (TEM)</title><p>Larvae were collected at 72 hpf and the final portion of the trunk was cut and used for genotyping. The larvae were immediately fixed in ice-cold 1% PFA, 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 30 min on ice, and then stored at 4°C overnight. Samples were washed in 0.1 M sodium cacodylate buffer and postfixed in 2% (w/v) OsO<sub>4</sub>, followed by <italic>en bloc</italic> staining with 2% uranyl acetate. Samples were dehydrated with a graded series of washes in acetone, transferred to acetone/Epon solutions, and eventually embedded in Epon. Ultra-thin sections (approximately 70 nm thick) obtained with a Reichert-Jung Ultracut E microtome were collected on copper slot grids. Sections were examined with a Jeol JEM-1400 Plus transmission electron microscope (Jeol, Japan), operated at an accelerating voltage of 120 kV. Digital images were recorded with an EM-14800 Ruby Digital CCD camera unit (3296px x 2472px).</p></sec><sec id="s4-16"><title>Heart isolation and transcriptome analysis</title><p>As the phenotype of <italic>alk5</italic> mutants is too mild to sort them at 56 hpf, we used the Alk5 inhibitor treatment (as described above) to obtain enough embryonic hearts for the transcriptomic analysis. Hearts from 56 hpf <italic>Tg(kdrl:EGFP)</italic> DMSO and Alk5 inhibitor treated embryos were manually dissected using forceps. Approximately 20 hearts per replicate were pooled, and total RNA was isolated using the miRNeasy micro kit, combined with on-column DNase digestion. Total RNA and library integrity were verified with LabChip Gx Touch 24 (Perkin Elmer). 100 ng of total RNA was used as input for VAHTS Stranded mRNA-seq Library (Vazyme) preparation, following manufacturer's protocol. Sequencing was performed on the NextSeq500 instrument (Illumina) using v2 chemistry, resulting in an average of 37M reads per library with 1 × 75 bp single end setup. The resulting raw reads were assessed for quality, adapter content and duplication rates with FastQC (available online at <ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/">http://www.bioinformatics.babraham.ac.uk/</ext-link> projects/fastqc). Reaper version 13–100 was used to trim reads with a quality drop below a mean of Q20 in a window of 10 nucleotides (<xref ref-type="bibr" rid="bib18">Davis et al., 2013</xref>). Only reads between 30 and 150 nucleotides were used in subsequent analyses. Trimmed and filtered reads were aligned versus the Ensembl Zebrafish genome version DanRer11 (GRCz11.92) using STAR 2.4.0a with the parameter ‘outFilterMismatchNoverLmax 0.1’ to increase the maximum ratio of mismatches to mapped length to 10% (<xref ref-type="bibr" rid="bib21">Dobin et al., 2013</xref>). The number of reads aligning to genes was counted with featureCounts 1.4.5-p1 tool from the Subread package (<xref ref-type="bibr" rid="bib61">Liao et al., 2014</xref>). Only reads mapping at least partially inside exons were admitted and aggregated per gene, while reads overlapping multiple genes or aligning to multiple regions were excluded from further analyses. Differentially expressed genes were identified using DESeq2 version 1.18.1 (<xref ref-type="bibr" rid="bib65">Love et al., 2014</xref>). To remove a batch effect from the comparison, the replicates were presented to DESeq2 as covariates (DMSO_1/Inhib_1 = 1, DMSO_2/Inhib_2 = 2). Genes were classified to be differentially expressed genes (DEG) with Benjamini-Hochberg corrected p-value&lt;0.05 and −0.59 ≤ Log2 FC ≥+0.59. The Ensembl annotation was enriched with UniProt data (release 06.06.2014) based on Ensembl gene identifiers (Activities at the Universal Protein Resource (UniProt)).</p><p>The raw count matrix was batch corrected using CountClust (<xref ref-type="bibr" rid="bib20">Dey et al., 2017</xref>) and then normalized with DESeq2. MA plots were produced to show DEG regulation per contrast.</p><p>Gene ontology enrichment of differentially expressed genes (log2FC&gt;|1|; P adjusted &lt;0.01) was calculated using cluster profiler (v 3.15.0) (<xref ref-type="bibr" rid="bib119">Yu et al., 2012</xref>) and with annotations derived from org.Dr.eg.db (v 3.10.0). Main overrepresented biological processes were identified and agglomerated based on manual inspection of significant Gene Ontology database gene sets with p-value&lt;0.01.</p></sec><sec id="s4-17"><title>RT-qPCR</title><p>Expression of <italic>alk5a</italic> and <italic>alk5b</italic> was analyzed in single 30 hpf larvae deriving from <italic>alk5a</italic> or <italic>alk5b</italic> heterozygous incrosses, respectively. DNA and RNA were extracted from single embryos using TRIzol reagent, followed by TRIzol-chloroform extracted, as previously described (<xref ref-type="bibr" rid="bib24">El-Brolosy et al., 2019</xref>). Briefly, RNA was extracted from the aqueous phase and stored with isopropanol at −80°C. DNA was then subsequently precipitated from the organic phase after the addition of ethanol and, then, treated with proteinase K, to allow efficient genotyping by HRM. After the genotyping, RNA from 5 to 10 embryos of the same genotype was pooled and extracted by precipitation. 500 ng mRNA was used to synthesize cDNA using the Maxima First Strand cDNA kit.</p><p>To analyze <italic>fbln5, efemp2b, sema3d, hmcn1</italic> and <italic>lum</italic> expression, hearts were manually dissected from 72 hpf larvae. <italic>alk5</italic> mutant hearts were selected based on the OFT phenotype and 15 hearts were pooled per replicate. For <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>, hearts were dissected and the body of the larva was genotyped. nine hearts were pooled according to the genotype. RNA was extracted as previously described for transcriptomic analyses.</p><p>For all the RT-qPCR experiments, DyNAmo ColorFlash SYBR Green qPCR Mix was used on a CFX connect Real-time System (Bio Rad).</p><p>All reactions were performed in technical triplicates and at least biological triplicates. For entire embryos qPCRs, every biological replicate consists of cDNA from a pool of 5–10 larvae per genotype, derived from independent crosses.</p><p>Gene expression values were normalized to the zebrafish <italic>rpl13a</italic> gene. Average Ct values for all conditions and details about statistical tests are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Sequences of qPCR primers are listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Radhan Ramadass for critical help with microscopy and all the fish facility staff for technical support, Rashmi Priya for the <italic>myl7:mScarlet-Hsa.HRAS</italic> plasmid and valuable suggestions, Matteo Perino for help with the analyses, discussions and critical comments on the manuscript, Sri Teja Mullapudi, Paolo Panza, Josephine Gollin, Felix Gunawan and Michelle Collins for suggestions and critical comments on the manuscript. Research in the Stainier lab is supported in part by the Max Planck Society, DFG (Sonderforschungsbereich) (SFB 834), the Leducq foundation, and the European Research Council (AdG project: ZMOD 694455).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior Editor eLife</p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Investigation, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All zebrafish husbandry was performed under standard conditions, and all experiments were conducted in accordance with institutional (MPG) and national ethical and animal welfare guidelines (Proposal numbers: B2/1017, B2/1041, B2/1218, B2/1138). All procedures conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of differentially expressed genes (&gt;1 or &lt;-1 log2FC) from RNA-seq dataset of 56 hpf dissected hearts from DMSO and Alk5 inhibitor-treated embryos.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57603-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Average Ct values of genes by RT-qPCR.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57603-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>RT-qPCR primer list.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57603-supp3-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-57603-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE143770. All other data generated or analysed during this study are included in the manuscript, figures and source data files.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Boezio</surname><given-names>GLM</given-names></name><name><surname>Bensimon-Brito</surname><given-names>A</given-names></name><name><surname>Piesker</surname><given-names>J</given-names></name><name><surname>Guenther</surname><given-names>S</given-names></name><name><surname>Helker</surname><given-names>CSM</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Identification of Alk5 targets zebrafish heart by transcriptomic analysis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143770">GSE143770</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albig</surname> <given-names>AR</given-names></name><name><surname>Schiemann</surname> <given-names>WP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells</article-title><source>DNA and Cell Biology</source><volume>23</volume><fpage>367</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1089/104454904323145254</pub-id><pub-id pub-id-type="pmid">15231070</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>RH</given-names></name><name><surname>Webb</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>NA</given-names></name><name><surname>Lamers</surname> <given-names>W</given-names></name><name><surname>Moorman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks</article-title><source>Heart</source><volume>89</volume><fpage>1110</fpage><lpage>1118</lpage><pub-id pub-id-type="doi">10.1136/heart.89.9.1110</pub-id><pub-id pub-id-type="pmid">12923046</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>RH</given-names></name><name><surname>Mori</surname> <given-names>S</given-names></name><name><surname>Spicer</surname> <given-names>DE</given-names></name><name><surname>Brown</surname> <given-names>NA</given-names></name><name><surname>Mohun</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Development and morphology of the ventricular outflow tracts</article-title><source>World Journal for Pediatric and Congenital Heart Surgery</source><volume>7</volume><fpage>561</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1177/2150135116651114</pub-id><pub-id pub-id-type="pmid">27587491</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname> <given-names>K</given-names></name><name><surname>Fukuhara</surname> <given-names>S</given-names></name><name><surname>Izumi</surname> <given-names>N</given-names></name><name><surname>Nakajima</surname> <given-names>H</given-names></name><name><surname>Fukui</surname> <given-names>H</given-names></name><name><surname>Kelsh</surname> <given-names>RN</given-names></name><name><surname>Mochizuki</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Clarification of mural cell coverage of vascular endothelial cells by live imaging of zebrafish</article-title><source>Development</source><volume>143</volume><fpage>1328</fpage><lpage>1339</lpage><pub-id pub-id-type="doi">10.1242/dev.132654</pub-id><pub-id pub-id-type="pmid">26952986</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspalter</surname> <given-names>IM</given-names></name><name><surname>Gordon</surname> <given-names>E</given-names></name><name><surname>Dubrac</surname> <given-names>A</given-names></name><name><surname>Ragab</surname> <given-names>A</given-names></name><name><surname>Narloch</surname> <given-names>J</given-names></name><name><surname>Vizán</surname> <given-names>P</given-names></name><name><surname>Geudens</surname> <given-names>I</given-names></name><name><surname>Collins</surname> <given-names>RT</given-names></name><name><surname>Franco</surname> <given-names>CA</given-names></name><name><surname>Abrahams</surname> <given-names>CL</given-names></name><name><surname>Thurston</surname> <given-names>G</given-names></name><name><surname>Fruttiger</surname> <given-names>M</given-names></name><name><surname>Rosewell</surname> <given-names>I</given-names></name><name><surname>Eichmann</surname> <given-names>A</given-names></name><name><surname>Gerhardt</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of notch</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7264</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8264</pub-id><pub-id pub-id-type="pmid">26081042</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajolle</surname> <given-names>F</given-names></name><name><surname>Zaffran</surname> <given-names>S</given-names></name><name><surname>Kelly</surname> <given-names>RG</given-names></name><name><surname>Hadchouel</surname> <given-names>J</given-names></name><name><surname>Bonnet</surname> <given-names>D</given-names></name><name><surname>Brown</surname> <given-names>NA</given-names></name><name><surname>Buckingham</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Rotation of the myocardial wall of the outflow tract is implicated in the normal positioning of the great arteries</article-title><source>Circulation Research</source><volume>98</volume><fpage>421</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000202800.85341.6e</pub-id><pub-id pub-id-type="pmid">16397144</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bochenek</surname> <given-names>ML</given-names></name><name><surname>Leidinger</surname> <given-names>C</given-names></name><name><surname>Rosinus</surname> <given-names>NS</given-names></name><name><surname>Gogiraju</surname> <given-names>R</given-names></name><name><surname>Guth</surname> <given-names>S</given-names></name><name><surname>Hobohm</surname> <given-names>L</given-names></name><name><surname>Jurk</surname> <given-names>K</given-names></name><name><surname>Mayer</surname> <given-names>E</given-names></name><name><surname>Münzel</surname> <given-names>T</given-names></name><name><surname>Lankeit</surname> <given-names>M</given-names></name><name><surname>Bosmann</surname> <given-names>M</given-names></name><name><surname>Konstantinides</surname> <given-names>S</given-names></name><name><surname>Schäfer</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Activated endothelial tgfβ1 signaling promotes venous Thrombus nonresolution in mice via Endothelin-1: potential role for chronic thromboembolic pulmonary hypertension</article-title><source>Circulation Research</source><volume>126</volume><fpage>162</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.119.315259</pub-id><pub-id pub-id-type="pmid">31747868</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brownstein</surname> <given-names>AJ</given-names></name><name><surname>Ziganshin</surname> <given-names>BA</given-names></name><name><surname>Kuivaniemi</surname> <given-names>H</given-names></name><name><surname>Body</surname> <given-names>SC</given-names></name><name><surname>Bale</surname> <given-names>AE</given-names></name><name><surname>Elefteriades</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genes associated with thoracic aortic aneurysm and dissection: an update and clinical implications</article-title><source>Aorta (Stamford)</source><volume> 5</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1055/s-0038-1639612</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckingham</surname> <given-names>M</given-names></name><name><surname>Meilhac</surname> <given-names>S</given-names></name><name><surname>Zaffran</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Building the mammalian heart from two sources of myocardial cells</article-title><source>Nature Reviews Genetics</source><volume>6</volume><fpage>826</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1038/nrg1710</pub-id><pub-id pub-id-type="pmid">16304598</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid BAC selection for tol2-mediated transgenesis in zebrafish</article-title><source>Development</source><volume>138</volume><fpage>4327</fpage><lpage>4332</lpage><pub-id pub-id-type="doi">10.1242/dev.068080</pub-id><pub-id pub-id-type="pmid">21865323</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>RL</given-names></name><name><surname>Itoh</surname> <given-names>F</given-names></name><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Lebrin</surname> <given-names>F</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Takahashi</surname> <given-names>S</given-names></name><name><surname>Ema</surname> <given-names>M</given-names></name><name><surname>Itoh</surname> <given-names>S</given-names></name><name><surname>van Rooijen</surname> <given-names>M</given-names></name><name><surname>Bertolino</surname> <given-names>P</given-names></name><name><surname>Ten Dijke</surname> <given-names>P</given-names></name><name><surname>Mummery</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice</article-title><source>Journal of Cell Science</source><volume>120</volume><fpage>4269</fpage><lpage>4277</lpage><pub-id pub-id-type="doi">10.1242/jcs.013169</pub-id><pub-id pub-id-type="pmid">18029401</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casari</surname> <given-names>A</given-names></name><name><surname>Schiavone</surname> <given-names>M</given-names></name><name><surname>Facchinello</surname> <given-names>N</given-names></name><name><surname>Vettori</surname> <given-names>A</given-names></name><name><surname>Meyer</surname> <given-names>D</given-names></name><name><surname>Tiso</surname> <given-names>N</given-names></name><name><surname>Moro</surname> <given-names>E</given-names></name><name><surname>Argenton</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A Smad3 transgenic reporter reveals TGF-beta control of zebrafish spinal cord development</article-title><source>Developmental Biology</source><volume>396</volume><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.09.025</pub-id><pub-id pub-id-type="pmid">25286120</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavanaugh</surname> <given-names>AM</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Two developmentally distinct populations of neural crest cells contribute to the zebrafish heart</article-title><source>Developmental Biology</source><volume>404</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.06.002</pub-id><pub-id pub-id-type="pmid">26086691</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname> <given-names>SL</given-names></name><name><surname>Sicot</surname> <given-names>FX</given-names></name><name><surname>Davis</surname> <given-names>EC</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Sasaki</surname> <given-names>T</given-names></name><name><surname>Chu</surname> <given-names>ML</given-names></name><name><surname>Yanagisawa</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic Lamina and protect from vascular injury</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>30</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.109.196725</pub-id><pub-id pub-id-type="pmid">19893004</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname> <given-names>B</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>P</given-names></name><name><surname>Thomas</surname> <given-names>S</given-names></name><name><surname>Kaartinen</surname> <given-names>V</given-names></name><name><surname>Sucov</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Absence of TGFbeta signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm</article-title><source>Genesis</source><volume>47</volume><fpage>115</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1002/dvg.20466</pub-id><pub-id pub-id-type="pmid">19165826</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname> <given-names>SI</given-names></name><name><surname>Magnusson</surname> <given-names>PU</given-names></name><name><surname>Dejana</surname> <given-names>E</given-names></name><name><surname>Lampugnani</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Deregulated TGF-β/BMP signaling in vascular malformations</article-title><source>Circulation Research</source><volume>121</volume><fpage>981</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309930</pub-id><pub-id pub-id-type="pmid">28963191</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dave</surname> <given-names>JM</given-names></name><name><surname>Mirabella</surname> <given-names>T</given-names></name><name><surname>Weatherbee</surname> <given-names>SD</given-names></name><name><surname>Greif</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pericyte ALK5/TIMP3 Axis contributes to endothelial morphogenesis in the developing brain</article-title><source>Developmental Cell</source><volume>44</volume><fpage>665</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.01.018</pub-id><pub-id pub-id-type="pmid">29456135</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>MP</given-names></name><name><surname>van Dongen</surname> <given-names>S</given-names></name><name><surname>Abreu-Goodger</surname> <given-names>C</given-names></name><name><surname>Bartonicek</surname> <given-names>N</given-names></name><name><surname>Enright</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Kraken: a set of tools for quality control and analysis of high-throughput sequence data</article-title><source>Methods</source><volume>63</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.06.027</pub-id><pub-id pub-id-type="pmid">23816787</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>GE</given-names></name><name><surname>Senger</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization</article-title><source>Circulation Research</source><volume>97</volume><fpage>1093</fpage><lpage>1107</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000191547.64391.e3</pub-id><pub-id pub-id-type="pmid">16306453</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname> <given-names>KK</given-names></name><name><surname>Hsiao</surname> <given-names>CJ</given-names></name><name><surname>Stephens</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Visualizing the structure of RNA-seq expression data using grade of membership models</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1006599</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006599</pub-id><pub-id pub-id-type="pmid">28333934</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogra</surname> <given-names>D</given-names></name><name><surname>Ahuja</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>HT</given-names></name><name><surname>Rasouli</surname> <given-names>SJ</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name><name><surname>Reischauer</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Opposite effects of activin type 2 receptor ligands on cardiomyocyte proliferation during development and repair</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1902</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01950-1</pub-id><pub-id pub-id-type="pmid">29196619</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duchemin</surname> <given-names>AL</given-names></name><name><surname>Vignes</surname> <given-names>H</given-names></name><name><surname>Vermot</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mechanically activated piezo channels modulate outflow tract valve development through the Yap1 and Klf2-Notch signaling Axis</article-title><source>eLife</source><volume>8</volume><elocation-id>e44706</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44706</pub-id><pub-id pub-id-type="pmid">31524599</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Brolosy</surname> <given-names>MA</given-names></name><name><surname>Kontarakis</surname> <given-names>Z</given-names></name><name><surname>Rossi</surname> <given-names>A</given-names></name><name><surname>Kuenne</surname> <given-names>C</given-names></name><name><surname>Günther</surname> <given-names>S</given-names></name><name><surname>Fukuda</surname> <given-names>N</given-names></name><name><surname>Kikhi</surname> <given-names>K</given-names></name><name><surname>Boezio</surname> <given-names>GLM</given-names></name><name><surname>Takacs</surname> <given-names>CM</given-names></name><name><surname>Lai</surname> <given-names>SL</given-names></name><name><surname>Fukuda</surname> <given-names>R</given-names></name><name><surname>Gerri</surname> <given-names>C</given-names></name><name><surname>Giraldez</surname> <given-names>AJ</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic compensation triggered by mutant mRNA degradation</article-title><source>Nature</source><volume>568</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1064-z</pub-id><pub-id pub-id-type="pmid">30944477</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felker</surname> <given-names>A</given-names></name><name><surname>Prummel</surname> <given-names>KD</given-names></name><name><surname>Merks</surname> <given-names>AM</given-names></name><name><surname>Mickoleit</surname> <given-names>M</given-names></name><name><surname>Brombacher</surname> <given-names>EC</given-names></name><name><surname>Huisken</surname> <given-names>J</given-names></name><name><surname>Panáková</surname> <given-names>D</given-names></name><name><surname>Mosimann</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Continuous addition of progenitors forms the cardiac ventricle in zebrafish</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2001</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04402-6</pub-id><pub-id pub-id-type="pmid">29784942</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaengel</surname> <given-names>K</given-names></name><name><surname>Genové</surname> <given-names>G</given-names></name><name><surname>Armulik</surname> <given-names>A</given-names></name><name><surname>Betsholtz</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Endothelial-mural cell signaling in vascular development and angiogenesis</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>29</volume><fpage>630</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.107.161521</pub-id><pub-id pub-id-type="pmid">19164813</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname> <given-names>JA</given-names></name><name><surname>Valen</surname> <given-names>E</given-names></name><name><surname>Thyme</surname> <given-names>SB</given-names></name><name><surname>Huang</surname> <given-names>P</given-names></name><name><surname>Akhmetova</surname> <given-names>L</given-names></name><name><surname>Ahkmetova</surname> <given-names>L</given-names></name><name><surname>Pauli</surname> <given-names>A</given-names></name><name><surname>Montague</surname> <given-names>TG</given-names></name><name><surname>Zimmerman</surname> <given-names>S</given-names></name><name><surname>Richter</surname> <given-names>C</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98186</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098186</pub-id><pub-id pub-id-type="pmid">24873830</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>T</given-names></name><name><surname>Raj</surname> <given-names>JU</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial and smooth muscle cell interactions in the pathobiology of pulmonary hypertension</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>54</volume><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2015-0323TR</pub-id><pub-id pub-id-type="pmid">26744837</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauvrit</surname> <given-names>S</given-names></name><name><surname>Villasenor</surname> <given-names>A</given-names></name><name><surname>Strilic</surname> <given-names>B</given-names></name><name><surname>Kitchen</surname> <given-names>P</given-names></name><name><surname>Collins</surname> <given-names>MM</given-names></name><name><surname>Marín-Juez</surname> <given-names>R</given-names></name><name><surname>Guenther</surname> <given-names>S</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Fukuda</surname> <given-names>N</given-names></name><name><surname>Canham</surname> <given-names>MA</given-names></name><name><surname>Brickman</surname> <given-names>JM</given-names></name><name><surname>Bogue</surname> <given-names>CW</given-names></name><name><surname>Jayaraman</surname> <given-names>PS</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling Axis during vascular development</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2704</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05039-1</pub-id><pub-id pub-id-type="pmid">30006544</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gellibert</surname> <given-names>F</given-names></name><name><surname>Woolven</surname> <given-names>J</given-names></name><name><surname>Fouchet</surname> <given-names>MH</given-names></name><name><surname>Mathews</surname> <given-names>N</given-names></name><name><surname>Goodland</surname> <given-names>H</given-names></name><name><surname>Lovegrove</surname> <given-names>V</given-names></name><name><surname>Laroze</surname> <given-names>A</given-names></name><name><surname>Nguyen</surname> <given-names>VL</given-names></name><name><surname>Sautet</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Janson</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>W</given-names></name><name><surname>Krysa</surname> <given-names>G</given-names></name><name><surname>Boullay</surname> <given-names>V</given-names></name><name><surname>De Gouville</surname> <given-names>AC</given-names></name><name><surname>Huet</surname> <given-names>S</given-names></name><name><surname>Hartley</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors</article-title><source>Journal of Medicinal Chemistry</source><volume>47</volume><fpage>4494</fpage><lpage>4506</lpage><pub-id pub-id-type="doi">10.1021/jm0400247</pub-id><pub-id pub-id-type="pmid">15317461</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillis</surname> <given-names>E</given-names></name><name><surname>Van Laer</surname> <given-names>L</given-names></name><name><surname>Loeys</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility</article-title><source>Circulation Research</source><volume>113</volume><fpage>327</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.300675</pub-id><pub-id pub-id-type="pmid">23868829</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Valdimarsdottir</surname> <given-names>G</given-names></name><name><surname>Itoh</surname> <given-names>S</given-names></name><name><surname>Rosendahl</surname> <given-names>A</given-names></name><name><surname>Sideras</surname> <given-names>P</given-names></name><name><surname>ten Dijke</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>1743</fpage><lpage>1753</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.7.1743</pub-id><pub-id pub-id-type="pmid">11927558</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Lebrin</surname> <given-names>F</given-names></name><name><surname>Valdimarsdottir</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways</article-title><source>Trends in Cardiovascular Medicine</source><volume>13</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/S1050-1738(03)00142-7</pub-id><pub-id pub-id-type="pmid">14522471</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Ten Dijke</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TGF-β signaling in control of cardiovascular function</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>10</volume><elocation-id>a022210</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a022210</pub-id><pub-id pub-id-type="pmid">28348036</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimes</surname> <given-names>AC</given-names></name><name><surname>Stadt</surname> <given-names>HA</given-names></name><name><surname>Shepherd</surname> <given-names>IT</given-names></name><name><surname>Kirby</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Solving an enigma: arterial pole development in the zebrafish heart</article-title><source>Developmental Biology</source><volume>290</volume><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.11.042</pub-id><pub-id pub-id-type="pmid">16405941</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimes</surname> <given-names>AC</given-names></name><name><surname>Durán</surname> <given-names>AC</given-names></name><name><surname>Sans-Coma</surname> <given-names>V</given-names></name><name><surname>Hami</surname> <given-names>D</given-names></name><name><surname>Santoro</surname> <given-names>MM</given-names></name><name><surname>Torres</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Phylogeny informs ontogeny: a proposed common theme in the arterial pole of the vertebrate heart</article-title><source>Evolution &amp; Development</source><volume>12</volume><fpage>552</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1111/j.1525-142X.2010.00441.x</pub-id><pub-id pub-id-type="pmid">21040422</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimes</surname> <given-names>AC</given-names></name><name><surname>Kirby</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The outflow tract of the heart in fishes: anatomy, genes and evolution</article-title><source>Journal of Fish Biology</source><volume>74</volume><fpage>983</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1111/j.1095-8649.2008.02125.x</pub-id><pub-id pub-id-type="pmid">20735616</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grönroos</surname> <given-names>E</given-names></name><name><surname>Kingston</surname> <given-names>IJ</given-names></name><name><surname>Ramachandran</surname> <given-names>A</given-names></name><name><surname>Randall</surname> <given-names>RA</given-names></name><name><surname>Vizán</surname> <given-names>P</given-names></name><name><surname>Hill</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes</article-title><source>Molecular and Cellular Biology</source><volume>32</volume><fpage>2904</fpage><lpage>2916</lpage><pub-id pub-id-type="doi">10.1128/MCB.00231-12</pub-id><pub-id pub-id-type="pmid">22615489</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunawan</surname> <given-names>F</given-names></name><name><surname>Gentile</surname> <given-names>A</given-names></name><name><surname>Fukuda</surname> <given-names>R</given-names></name><name><surname>Tsedeke</surname> <given-names>AT</given-names></name><name><surname>Jiménez-Amilburu</surname> <given-names>V</given-names></name><name><surname>Ramadass</surname> <given-names>R</given-names></name><name><surname>Iida</surname> <given-names>A</given-names></name><name><surname>Sehara-Fujisawa</surname> <given-names>A</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Focal adhesions are essential to drive zebrafish heart valve morphogenesis</article-title><source>Journal of Cell Biology</source><volume>218</volume><fpage>1039</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1083/jcb.201807175</pub-id><pub-id pub-id-type="pmid">30635353</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>SY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transforming growth factor-β and smooth muscle differentiation</article-title><source>World Journal of Biological Chemistry</source><volume>3</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.4331/wjbc.v3.i3.41</pub-id><pub-id pub-id-type="pmid">22451850</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hami</surname> <given-names>D</given-names></name><name><surname>Grimes</surname> <given-names>AC</given-names></name><name><surname>Tsai</surname> <given-names>HJ</given-names></name><name><surname>Kirby</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zebrafish cardiac development requires a conserved secondary heart field</article-title><source>Development</source><volume>138</volume><fpage>2389</fpage><lpage>2398</lpage><pub-id pub-id-type="doi">10.1242/dev.061473</pub-id><pub-id pub-id-type="pmid">21558385</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatta</surname> <given-names>K</given-names></name><name><surname>Tsujii</surname> <given-names>H</given-names></name><name><surname>Omura</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cell tracking using a photoconvertible fluorescent protein</article-title><source>Nature Protocols</source><volume>1</volume><fpage>960</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.96</pub-id><pub-id pub-id-type="pmid">17406330</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herwig</surname> <given-names>L</given-names></name><name><surname>Blum</surname> <given-names>Y</given-names></name><name><surname>Krudewig</surname> <given-names>A</given-names></name><name><surname>Ellertsdottir</surname> <given-names>E</given-names></name><name><surname>Lenard</surname> <given-names>A</given-names></name><name><surname>Belting</surname> <given-names>HG</given-names></name><name><surname>Affolter</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct cellular mechanisms of blood vessel fusion in the zebrafish embryo</article-title><source>Current Biology</source><volume>21</volume><fpage>1942</fpage><lpage>1948</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2011.10.016</pub-id><pub-id pub-id-type="pmid">22079115</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtzhausen</surname> <given-names>A</given-names></name><name><surname>Golzio</surname> <given-names>C</given-names></name><name><surname>How</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>YH</given-names></name><name><surname>Schiemann</surname> <given-names>WP</given-names></name><name><surname>Katsanis</surname> <given-names>N</given-names></name><name><surname>Blobe</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate Cancer progression and development</article-title><source>The FASEB Journal</source><volume>28</volume><fpage>1248</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1096/fj.13-239178</pub-id><pub-id pub-id-type="pmid">24308972</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffe</surname> <given-names>M</given-names></name><name><surname>Sesti</surname> <given-names>C</given-names></name><name><surname>Washington</surname> <given-names>IM</given-names></name><name><surname>Du</surname> <given-names>L</given-names></name><name><surname>Dronadula</surname> <given-names>N</given-names></name><name><surname>Chin</surname> <given-names>MT</given-names></name><name><surname>Stolz</surname> <given-names>DB</given-names></name><name><surname>Davis</surname> <given-names>EC</given-names></name><name><surname>Dichek</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transforming growth factor-β signaling in myogenic cells regulates vascular morphogenesis, differentiation, and matrix synthesis</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>32</volume><fpage>e1</fpage><lpage>e11</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.238410</pub-id><pub-id pub-id-type="pmid">21979435</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahangiri</surname> <given-names>L</given-names></name><name><surname>Sharpe</surname> <given-names>M</given-names></name><name><surname>Novikov</surname> <given-names>N</given-names></name><name><surname>González-Rosa</surname> <given-names>JM</given-names></name><name><surname>Borikova</surname> <given-names>A</given-names></name><name><surname>Nevis</surname> <given-names>K</given-names></name><name><surname>Paffett-Lugassy</surname> <given-names>N</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Adams</surname> <given-names>M</given-names></name><name><surname>Guner-Ataman</surname> <given-names>B</given-names></name><name><surname>Burns</surname> <given-names>CE</given-names></name><name><surname>Burns</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The AP-1 transcription factor component Fosl2 potentiates the rate of myocardial differentiation from the zebrafish second heart field</article-title><source>Development</source><volume>143</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1242/dev.126136</pub-id><pub-id pub-id-type="pmid">26732840</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>SW</given-names></name><name><surname>Beis</surname> <given-names>D</given-names></name><name><surname>Mitchell</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>JN</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cellular and molecular analyses of vascular tube and lumen formation in zebrafish</article-title><source>Development</source><volume>132</volume><fpage>5199</fpage><lpage>5209</lpage><pub-id pub-id-type="doi">10.1242/dev.02087</pub-id><pub-id pub-id-type="pmid">16251212</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jinnin</surname> <given-names>M</given-names></name><name><surname>Ihn</surname> <given-names>H</given-names></name><name><surname>Tamaki</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression</article-title><source>Molecular Pharmacology</source><volume>69</volume><fpage>597</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1124/mol.105.017483</pub-id><pub-id pub-id-type="pmid">16288083</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>JA</given-names></name><name><surname>Spinale</surname> <given-names>FG</given-names></name><name><surname>Ikonomidis</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis</article-title><source>Journal of Vascular Research</source><volume>46</volume><fpage>119</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1159/000151766</pub-id><pub-id pub-id-type="pmid">18765947</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelleher</surname> <given-names>CM</given-names></name><name><surname>McLean</surname> <given-names>SE</given-names></name><name><surname>Mecham</surname> <given-names>RP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Vascular extracellular matrix and aortic development</article-title><source>Current Topics in Developmental Biology</source><volume>62</volume><fpage>153</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/S0070-2153(04)62006-0</pub-id><pub-id pub-id-type="pmid">15522742</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>RG</given-names></name><name><surname>Buckingham</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The anterior heart-forming field: voyage to the arterial pole of the heart</article-title><source>Trends in Genetics</source><volume>18</volume><fpage>210</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S0168-9525(02)02642-2</pub-id><pub-id pub-id-type="pmid">11932022</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname> <given-names>K</given-names></name><name><surname>Holdway</surname> <given-names>JE</given-names></name><name><surname>Major</surname> <given-names>RJ</given-names></name><name><surname>Blum</surname> <given-names>N</given-names></name><name><surname>Dahn</surname> <given-names>RD</given-names></name><name><surname>Begemann</surname> <given-names>G</given-names></name><name><surname>Poss</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Retinoic acid production by endocardium and epicardium is an injury response essential for zebrafish heart regeneration</article-title><source>Developmental Cell</source><volume>20</volume><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.01.010</pub-id><pub-id pub-id-type="pmid">21397850</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>JH</given-names></name><name><surname>Lee</surname> <given-names>SR</given-names></name><name><surname>Li</surname> <given-names>LH</given-names></name><name><surname>Park</surname> <given-names>HJ</given-names></name><name><surname>Park</surname> <given-names>JH</given-names></name><name><surname>Lee</surname> <given-names>KY</given-names></name><name><surname>Kim</surname> <given-names>MK</given-names></name><name><surname>Shin</surname> <given-names>BA</given-names></name><name><surname>Choi</surname> <given-names>SY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e18556</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0018556</pub-id><pub-id pub-id-type="pmid">21602908</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>HW</given-names></name><name><surname>Stansfield</surname> <given-names>BK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic and epigenetic regulation of aortic aneurysms</article-title><source>BioMed Research International</source><volume>2017</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2017/7268521</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knight</surname> <given-names>HG</given-names></name><name><surname>Yelon</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><chapter-title>Utilizing Zebrafish to Understand Second Heart Field Development</chapter-title><person-group person-group-type="editor"><name><surname>Nakanishi</surname> <given-names>T</given-names></name><name><surname>Markwald</surname> <given-names>R. R</given-names></name><name><surname>Baldwin</surname> <given-names>H. S</given-names></name><name><surname>Keller</surname> <given-names>B. B</given-names></name><name><surname>Srivastava</surname> <given-names>D</given-names></name><name><surname>Yamagishi</surname> <given-names>H</given-names></name></person-group><source>Etiology and Morphogenesis of Congenital Heart Disease: From Gene Function and Cellular Interaction to Morphology</source><publisher-loc>Tokyo</publisher-loc><publisher-name>Springer</publisher-name><fpage>193</fpage><lpage>199</lpage></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname> <given-names>PP</given-names></name><name><surname>Joyce-Brady</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>XH</given-names></name><name><surname>Jean</surname> <given-names>JC</given-names></name><name><surname>Goldstein</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>291</volume><fpage>C1412</fpage><lpage>C1421</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00087.2006</pub-id><pub-id pub-id-type="pmid">16837650</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebrin</surname> <given-names>F</given-names></name><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Jonker</surname> <given-names>L</given-names></name><name><surname>Carvalho</surname> <given-names>RL</given-names></name><name><surname>Valdimarsdottir</surname> <given-names>G</given-names></name><name><surname>Thorikay</surname> <given-names>M</given-names></name><name><surname>Mummery</surname> <given-names>C</given-names></name><name><surname>Arthur</surname> <given-names>HM</given-names></name><name><surname>ten Dijke</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>4018</fpage><lpage>4028</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600386</pub-id><pub-id pub-id-type="pmid">15385967</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KF</given-names></name><name><surname>Simon</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Bates</surname> <given-names>B</given-names></name><name><surname>Hung</surname> <given-names>MC</given-names></name><name><surname>Hauser</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Requirement for neuregulin receptor erbB2 in neural and cardiac development</article-title><source>Nature</source><volume>378</volume><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1038/378394a0</pub-id><pub-id pub-id-type="pmid">7477377</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Jiao</surname> <given-names>Y</given-names></name><name><surname>Qin</surname> <given-names>L</given-names></name><name><surname>Ali</surname> <given-names>R</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Ferruzzi</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>RW</given-names></name><name><surname>Geirsson</surname> <given-names>A</given-names></name><name><surname>Dietz</surname> <given-names>HC</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name><name><surname>Humphrey</surname> <given-names>JD</given-names></name><name><surname>Tellides</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>755</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1172/JCI69942</pub-id><pub-id pub-id-type="pmid">24401272</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Qian</surname> <given-names>M</given-names></name><name><surname>Kyler</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelial-Vascular smooth muscle cells interactions in atherosclerosis</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>5</volume><elocation-id>151</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2018.00151</pub-id><pub-id pub-id-type="pmid">30406116</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lilly</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>We have contact: endothelial cell-smooth muscle cell interactions</article-title><source>Physiology</source><volume>29</volume><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1152/physiol.00047.2013</pub-id><pub-id pub-id-type="pmid">24985327</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>F</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TGF-β signaling in aortic aneurysm: another round of controversy</article-title><source>Journal of Genetics and Genomics</source><volume>37</volume><fpage>583</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1016/S1673-8527(09)60078-3</pub-id><pub-id pub-id-type="pmid">20933212</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Priest</surname> <given-names>JR</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell RNA-Seq of the developing cardiac outflow tract reveals convergent development of the vascular smooth muscle cells</article-title><source>Cell Reports</source><volume>28</volume><fpage>1346</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.092</pub-id><pub-id pub-id-type="pmid">31365875</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallat</surname> <given-names>Z</given-names></name><name><surname>Ait-Oufella</surname> <given-names>H</given-names></name><name><surname>Tedgui</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The pathogenic transforming growth Factor-β overdrive hypothesis in aortic aneurysms and dissections: a mirage?</article-title><source>Circulation Research</source><volume>120</volume><fpage>1718</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.310371</pub-id><pub-id pub-id-type="pmid">28546355</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname> <given-names>ML</given-names></name><name><surname>Terzic</surname> <given-names>A</given-names></name><name><surname>Conley</surname> <given-names>BA</given-names></name><name><surname>Oxburgh</surname> <given-names>LH</given-names></name><name><surname>Nicola</surname> <given-names>T</given-names></name><name><surname>Vary</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis</article-title><source>Developmental Dynamics</source><volume>238</volume><fpage>2479</fpage><lpage>2493</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22066</pub-id><pub-id pub-id-type="pmid">19705428</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maring</surname> <given-names>JA</given-names></name><name><surname>van Meeteren</surname> <given-names>LA</given-names></name><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>Ten Dijke</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interrogating TGF-β function and regulation in endothelial cells</article-title><source>Methods in Molecular Biology</source><volume>1344</volume><fpage>193</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2966-5_11</pub-id><pub-id pub-id-type="pmid">26520125</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massagué</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tgfβ signalling in context</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>13</volume><fpage>616</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1038/nrm3434</pub-id><pub-id pub-id-type="pmid">22992590</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname> <given-names>RL</given-names></name><name><surname>Marass</surname> <given-names>M</given-names></name><name><surname>Avdesh</surname> <given-names>A</given-names></name><name><surname>Helker</surname> <given-names>CS</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Grosse</surname> <given-names>AS</given-names></name><name><surname>Kaur</surname> <given-names>H</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name><name><surname>Herzog</surname> <given-names>W</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Radial Glia regulate vascular patterning around the developing spinal cord</article-title><source>eLife</source><volume>5</volume><elocation-id>e20253</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.20253</pub-id><pub-id pub-id-type="pmid">27852438</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meilhac</surname> <given-names>SM</given-names></name><name><surname>Lescroart</surname> <given-names>F</given-names></name><name><surname>Blanpain</surname> <given-names>C</given-names></name><name><surname>Buckingham</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cardiac cell lineages that form the heart</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>4</volume><elocation-id>a013888</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a013888</pub-id><pub-id pub-id-type="pmid">25183852</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname> <given-names>D</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Multiple essential functions of neuregulin in development</article-title><source>Nature</source><volume>378</volume><fpage>386</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1038/378386a0</pub-id><pub-id pub-id-type="pmid">7477375</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>M</given-names></name><name><surname>Bruce</surname> <given-names>AE</given-names></name><name><surname>Bhanji</surname> <given-names>T</given-names></name><name><surname>Davis</surname> <given-names>EC</given-names></name><name><surname>Keeley</surname> <given-names>FW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Differential expression of two tropoelastin genes in zebrafish</article-title><source>Matrix Biology</source><volume>26</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2006.09.011</pub-id><pub-id pub-id-type="pmid">17112714</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mjaatvedt</surname> <given-names>CH</given-names></name><name><surname>Nakaoka</surname> <given-names>T</given-names></name><name><surname>Moreno-Rodriguez</surname> <given-names>R</given-names></name><name><surname>Norris</surname> <given-names>RA</given-names></name><name><surname>Kern</surname> <given-names>MJ</given-names></name><name><surname>Eisenberg</surname> <given-names>CA</given-names></name><name><surname>Turner</surname> <given-names>D</given-names></name><name><surname>Markwald</surname> <given-names>RR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The outflow tract of the heart is recruited from a novel heart-forming field</article-title><source>Developmental Biology</source><volume>238</volume><fpage>97</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1006/dbio.2001.0409</pub-id><pub-id pub-id-type="pmid">11783996</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullapudi</surname> <given-names>ST</given-names></name><name><surname>Helker</surname> <given-names>CS</given-names></name><name><surname>Boezio</surname> <given-names>GL</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Sokol</surname> <given-names>AM</given-names></name><name><surname>Guenther</surname> <given-names>S</given-names></name><name><surname>Matsuda</surname> <given-names>H</given-names></name><name><surname>Kubicek</surname> <given-names>S</given-names></name><name><surname>Graumann</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>YHC</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Screening for insulin-independent pathways that modulate glucose homeostasis identifies androgen receptor antagonists</article-title><source>eLife</source><volume>7</volume><elocation-id>e42209</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42209</pub-id><pub-id pub-id-type="pmid">30520733</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Ruiz-Lozano</surname> <given-names>P</given-names></name><name><surname>Lindner</surname> <given-names>V</given-names></name><name><surname>Yabe</surname> <given-names>D</given-names></name><name><surname>Taniwaki</surname> <given-names>M</given-names></name><name><surname>Furukawa</surname> <given-names>Y</given-names></name><name><surname>Kobuke</surname> <given-names>K</given-names></name><name><surname>Tashiro</surname> <given-names>K</given-names></name><name><surname>Lu</surname> <given-names>Z</given-names></name><name><surname>Andon</surname> <given-names>NL</given-names></name><name><surname>Schaub</surname> <given-names>R</given-names></name><name><surname>Matsumori</surname> <given-names>A</given-names></name><name><surname>Sasayama</surname> <given-names>S</given-names></name><name><surname>Chien</surname> <given-names>KR</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>22476</fpage><lpage>22483</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.32.22476</pub-id><pub-id pub-id-type="pmid">10428823</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Lozano</surname> <given-names>PR</given-names></name><name><surname>Ikeda</surname> <given-names>Y</given-names></name><name><surname>Iwanaga</surname> <given-names>Y</given-names></name><name><surname>Hinek</surname> <given-names>A</given-names></name><name><surname>Minamisawa</surname> <given-names>S</given-names></name><name><surname>Cheng</surname> <given-names>CF</given-names></name><name><surname>Kobuke</surname> <given-names>K</given-names></name><name><surname>Dalton</surname> <given-names>N</given-names></name><name><surname>Takada</surname> <given-names>Y</given-names></name><name><surname>Tashiro</surname> <given-names>K</given-names></name><name><surname>Ross</surname> <given-names>J</given-names></name><name><surname>Honjo</surname> <given-names>T</given-names></name><name><surname>Chien</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Fibulin-5/DANCE is essential for elastogenesis <italic>in vivo</italic></article-title><source>Nature</source><volume>415</volume><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/415171a</pub-id><pub-id pub-id-type="pmid">11805835</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nauroy</surname> <given-names>P</given-names></name><name><surname>Hughes</surname> <given-names>S</given-names></name><name><surname>Naba</surname> <given-names>A</given-names></name><name><surname>Ruggiero</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The in-silico zebrafish matrisome: a new tool to study extracellular matrix gene and protein functions</article-title><source>Matrix Biology</source><volume>65</volume><fpage>5</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2017.07.001</pub-id><pub-id pub-id-type="pmid">28739138</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neeb</surname> <given-names>Z</given-names></name><name><surname>Lajiness</surname> <given-names>JD</given-names></name><name><surname>Bolanis</surname> <given-names>E</given-names></name><name><surname>Conway</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cardiac outflow tract anomalies</article-title><source>Wiley Interdisciplinary Reviews: Developmental Biology</source><volume>2</volume><fpage>499</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1002/wdev.98</pub-id><pub-id pub-id-type="pmid">24014420</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoli</surname> <given-names>S</given-names></name><name><surname>Standley</surname> <given-names>C</given-names></name><name><surname>Walker</surname> <given-names>P</given-names></name><name><surname>Hurlstone</surname> <given-names>A</given-names></name><name><surname>Fogarty</surname> <given-names>KE</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MicroRNA-mediated integration of haemodynamics and vegf signalling during angiogenesis</article-title><source>Nature</source><volume>464</volume><fpage>1196</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1038/nature08889</pub-id><pub-id pub-id-type="pmid">20364122</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paffett-Lugassy</surname> <given-names>N</given-names></name><name><surname>Novikov</surname> <given-names>N</given-names></name><name><surname>Jeffrey</surname> <given-names>S</given-names></name><name><surname>Abrial</surname> <given-names>M</given-names></name><name><surname>Guner-Ataman</surname> <given-names>B</given-names></name><name><surname>Sakthivel</surname> <given-names>S</given-names></name><name><surname>Burns</surname> <given-names>CE</given-names></name><name><surname>Burns</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Unique developmental trajectories and genetic regulation of ventricular and outflow tract progenitors in the zebrafish second heart field</article-title><source>Development</source><volume>144</volume><fpage>4616</fpage><lpage>4624</lpage><pub-id pub-id-type="doi">10.1242/dev.153411</pub-id><pub-id pub-id-type="pmid">29061637</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardali</surname> <given-names>E</given-names></name><name><surname>Goumans</surname> <given-names>MJ</given-names></name><name><surname>ten Dijke</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Signaling by members of the TGF-beta family in vascular morphogenesis and disease</article-title><source>Trends in Cell Biology</source><volume>20</volume><fpage>556</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2010.06.006</pub-id><pub-id pub-id-type="pmid">20656490</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauli</surname> <given-names>A</given-names></name><name><surname>Valen</surname> <given-names>E</given-names></name><name><surname>Lin</surname> <given-names>MF</given-names></name><name><surname>Garber</surname> <given-names>M</given-names></name><name><surname>Vastenhouw</surname> <given-names>NL</given-names></name><name><surname>Levin</surname> <given-names>JZ</given-names></name><name><surname>Fan</surname> <given-names>L</given-names></name><name><surname>Sandelin</surname> <given-names>A</given-names></name><name><surname>Rinn</surname> <given-names>JL</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis</article-title><source>Genome Research</source><volume>22</volume><fpage>577</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1101/gr.133009.111</pub-id><pub-id pub-id-type="pmid">22110045</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrucci</surname> <given-names>GL</given-names></name><name><surname>Rurali</surname> <given-names>E</given-names></name><name><surname>Gowran</surname> <given-names>A</given-names></name><name><surname>Pini</surname> <given-names>A</given-names></name><name><surname>Antona</surname> <given-names>C</given-names></name><name><surname>Chiesa</surname> <given-names>R</given-names></name><name><surname>Pompilio</surname> <given-names>G</given-names></name><name><surname>Nigro</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Vascular smooth muscle cells in marfan syndrome aneurysm: the broken bricks in the aortic wall</article-title><source>Cellular and Molecular Life Sciences</source><volume>74</volume><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1007/s00018-016-2324-9</pub-id><pub-id pub-id-type="pmid">27535662</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preis</surname> <given-names>M</given-names></name><name><surname>Cohen</surname> <given-names>T</given-names></name><name><surname>Sarnatzki</surname> <given-names>Y</given-names></name><name><surname>Ben Yosef</surname> <given-names>Y</given-names></name><name><surname>Schneiderman</surname> <given-names>J</given-names></name><name><surname>Gluzman</surname> <given-names>Z</given-names></name><name><surname>Koren</surname> <given-names>B</given-names></name><name><surname>Lewis</surname> <given-names>BS</given-names></name><name><surname>Shaul</surname> <given-names>Y</given-names></name><name><surname>Flugelman</surname> <given-names>MY</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>348</volume><fpage>1024</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.07.156</pub-id><pub-id pub-id-type="pmid">16904068</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raines</surname> <given-names>EW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease</article-title><source>International Journal of Experimental Pathology</source><volume>81</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2613.2000.00155.x</pub-id><pub-id pub-id-type="pmid">10971738</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambeau</surname> <given-names>P</given-names></name><name><surname>Faure</surname> <given-names>E</given-names></name><name><surname>Théron</surname> <given-names>A</given-names></name><name><surname>Avierinos</surname> <given-names>JF</given-names></name><name><surname>Jopling</surname> <given-names>C</given-names></name><name><surname>Zaffran</surname> <given-names>S</given-names></name><name><surname>Faucherre</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Reduced aggrecan expression affects cardiac outflow tract development in zebrafish and is associated with bicuspid aortic valve disease in humans</article-title><source>International Journal of Cardiology</source><volume>249</volume><fpage>340</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2017.09.174</pub-id><pub-id pub-id-type="pmid">28986054</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasouli</surname> <given-names>SJ</given-names></name><name><surname>El-Brolosy</surname> <given-names>M</given-names></name><name><surname>Tsedeke</surname> <given-names>AT</given-names></name><name><surname>Bensimon-Brito</surname> <given-names>A</given-names></name><name><surname>Ghanbari</surname> <given-names>P</given-names></name><name><surname>Maischein</surname> <given-names>HM</given-names></name><name><surname>Kuenne</surname> <given-names>C</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The flow responsive transcription factor Klf2 is required for myocardial wall integrity by modulating fgf signaling</article-title><source>eLife</source><volume>7</volume><elocation-id>e38889</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38889</pub-id><pub-id pub-id-type="pmid">30592462</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasouli</surname> <given-names>SJ</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulation of cardiomyocyte behavior in zebrafish trabeculation by neuregulin 2a signaling</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15281</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15281</pub-id><pub-id pub-id-type="pmid">28485381</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothenberg</surname> <given-names>F</given-names></name><name><surname>Fisher</surname> <given-names>SA</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Sculpting the cardiac outflow tract</article-title><source>Birth Defects Research Part C: Embryo Today: Reviews</source><volume>69</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1002/bdrc.10007</pub-id><pub-id pub-id-type="pmid">12768656</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname> <given-names>J</given-names></name><name><surname>Arganda-Carreras</surname> <given-names>I</given-names></name><name><surname>Frise</surname> <given-names>E</given-names></name><name><surname>Kaynig</surname> <given-names>V</given-names></name><name><surname>Longair</surname> <given-names>M</given-names></name><name><surname>Pietzsch</surname> <given-names>T</given-names></name><name><surname>Preibisch</surname> <given-names>S</given-names></name><name><surname>Rueden</surname> <given-names>C</given-names></name><name><surname>Saalfeld</surname> <given-names>S</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Tinevez</surname> <given-names>JY</given-names></name><name><surname>White</surname> <given-names>DJ</given-names></name><name><surname>Hartenstein</surname> <given-names>V</given-names></name><name><surname>Eliceiri</surname> <given-names>K</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Cardona</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segers</surname> <given-names>VFM</given-names></name><name><surname>Brutsaert</surname> <given-names>DL</given-names></name><name><surname>De Keulenaer</surname> <given-names>GW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cardiac remodeling: endothelial cells have more to say than just NO</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>382</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00382</pub-id><pub-id pub-id-type="pmid">29695980</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seki</surname> <given-names>T</given-names></name><name><surname>Hong</surname> <given-names>KH</given-names></name><name><surname>Oh</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development</article-title><source>Laboratory Investigation</source><volume>86</volume><fpage>116</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3700376</pub-id><pub-id pub-id-type="pmid">16344855</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Sidhwani</surname> <given-names>P</given-names></name><name><surname>Boezio</surname> <given-names>GLM</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Roman</surname> <given-names>BL</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name><name><surname>Yelon</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cardiac function modulates endocardial cell dynamics to shape the cardiac outflow tract</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/787358</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>AR</given-names></name><name><surname>Sivadas</surname> <given-names>A</given-names></name><name><surname>Sabharwal</surname> <given-names>A</given-names></name><name><surname>Vellarikal</surname> <given-names>SK</given-names></name><name><surname>Jayarajan</surname> <given-names>R</given-names></name><name><surname>Verma</surname> <given-names>A</given-names></name><name><surname>Kapoor</surname> <given-names>S</given-names></name><name><surname>Joshi</surname> <given-names>A</given-names></name><name><surname>Scaria</surname> <given-names>V</given-names></name><name><surname>Sivasubbu</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chamber specific gene expression landscape of the zebrafish heart</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0147823</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0147823</pub-id><pub-id pub-id-type="pmid">26815362</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridurongrit</surname> <given-names>S</given-names></name><name><surname>Larsson</surname> <given-names>J</given-names></name><name><surname>Schwartz</surname> <given-names>R</given-names></name><name><surname>Ruiz-Lozano</surname> <given-names>P</given-names></name><name><surname>Kaartinen</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Signaling via the Tgf-beta type I receptor Alk5 in heart development</article-title><source>Developmental Biology</source><volume>322</volume><fpage>208</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.07.038</pub-id><pub-id pub-id-type="pmid">18718461</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Fishman</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>The zebrafish as a model system to study cardiovascular development</article-title><source>Trends in Cardiovascular Medicine</source><volume>4</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/1050-1738(94)90036-1</pub-id><pub-id pub-id-type="pmid">21244869</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratman</surname> <given-names>AN</given-names></name><name><surname>Pezoa</surname> <given-names>SA</given-names></name><name><surname>Farrelly</surname> <given-names>OM</given-names></name><name><surname>Castranova</surname> <given-names>D</given-names></name><name><surname>Dye</surname> <given-names>LE</given-names></name><name><surname>Butler</surname> <given-names>MG</given-names></name><name><surname>Sidik</surname> <given-names>H</given-names></name><name><surname>Talbot</surname> <given-names>WS</given-names></name><name><surname>Weinstein</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Interactions between mural cells and endothelial cells stabilize the developing zebrafish dorsal aorta</article-title><source>Development</source><volume>144</volume><fpage>115</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1242/dev.143131</pub-id><pub-id pub-id-type="pmid">27913637</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugishita</surname> <given-names>Y</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Fisher</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The development of the embryonic outflow tract provides novel insights into cardiac differentiation and remodeling</article-title><source>Trends in Cardiovascular Medicine</source><volume>14</volume><fpage>235</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2004.06.004</pub-id><pub-id pub-id-type="pmid">15451515</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>KM</given-names></name><name><surname>Bissonnette</surname> <given-names>R</given-names></name><name><surname>Yanagisawa</surname> <given-names>H</given-names></name><name><surname>Hussain</surname> <given-names>SN</given-names></name><name><surname>Davis</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Fibulin-5 functions as an endogenous angiogenesis inhibitor</article-title><source>Laboratory Investigation</source><volume>87</volume><fpage>818</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3700594</pub-id><pub-id pub-id-type="pmid">17607303</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Deng</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Xiong</surname> <given-names>X</given-names></name><name><surname>Gao</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endothelium as a potential target for treatment of abdominal aortic aneurysm</article-title><source>Oxidative Medicine and Cellular Longevity</source><volume>2018</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2018/6306542</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname> <given-names>M</given-names></name><name><surname>Foldes</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>It takes two: endothelial-perivascular cell Cross-Talk in vascular development and disease</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>5</volume><elocation-id>154</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2018.00154</pub-id><pub-id pub-id-type="pmid">30425990</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Tabula Muris Consortium</collab><collab>Overall coordination</collab><collab>Logistical coordination</collab><collab>Organ collection and processing</collab><collab>Library preparation and sequencing</collab><collab>Computational data analysis</collab><collab>Cell type annotation</collab><collab>Writing group</collab><collab>Supplemental text writing group</collab><collab>Principal investigators</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell transcriptomics of 20 mouse organs creates a tabula muris</article-title><source>Nature</source><volume>562</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0590-4</pub-id><pub-id pub-id-type="pmid">30283141</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname> <given-names>N</given-names></name><name><surname>Hara</surname> <given-names>H</given-names></name><name><surname>Fujiwara</surname> <given-names>T</given-names></name><name><surname>Kanaya</surname> <given-names>T</given-names></name><name><surname>Maemura</surname> <given-names>S</given-names></name><name><surname>Komuro</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TGF-β Signaling-Related genes and thoracic aortic aneurysms and dissections</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>2125</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19072125</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname> <given-names>C</given-names></name><name><surname>Thisse</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution <italic>in situ</italic> hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorovic</surname> <given-names>V</given-names></name><name><surname>Frendewey</surname> <given-names>D</given-names></name><name><surname>Gutstein</surname> <given-names>DE</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Freyer</surname> <given-names>L</given-names></name><name><surname>Finnegan</surname> <given-names>E</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Murphy</surname> <given-names>A</given-names></name><name><surname>Valenzuela</surname> <given-names>D</given-names></name><name><surname>Yancopoulos</surname> <given-names>G</given-names></name><name><surname>Rifkin</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Long form of latent TGF-Â binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling</article-title><source>Development</source><volume>134</volume><fpage>3723</fpage><lpage>3732</lpage><pub-id pub-id-type="doi">10.1242/dev.008599</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topalovski</surname> <given-names>M</given-names></name><name><surname>Hagopian</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Brekken</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hypoxia and transforming growth factor β cooperate to induce Fibulin-5 expression in pancreatic Cancer</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>22244</fpage><lpage>22252</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.730945</pub-id><pub-id pub-id-type="pmid">27531748</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Pol</surname> <given-names>V</given-names></name><name><surname>Kurakula</surname> <given-names>K</given-names></name><name><surname>DeRuiter</surname> <given-names>MC</given-names></name><name><surname>Goumans</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Thoracic aortic aneurysm development in patients with bicuspid aortic valve: what is the role of endothelial cells?</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>938</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00938</pub-id><pub-id pub-id-type="pmid">29249976</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Meeteren</surname> <given-names>LA</given-names></name><name><surname>ten Dijke</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of endothelial cell plasticity by TGF-β</article-title><source>Cell and Tissue Research</source><volume>347</volume><fpage>177</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1007/s00441-011-1222-6</pub-id><pub-id pub-id-type="pmid">21866313</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname> <given-names>GK</given-names></name><name><surname>Pei</surname> <given-names>W</given-names></name><name><surname>LaFave</surname> <given-names>MC</given-names></name><name><surname>Idol</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Gallardo</surname> <given-names>V</given-names></name><name><surname>Carrington</surname> <given-names>B</given-names></name><name><surname>Bishop</surname> <given-names>K</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Harper</surname> <given-names>U</given-names></name><name><surname>Huang</surname> <given-names>SC</given-names></name><name><surname>Prakash</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Sood</surname> <given-names>R</given-names></name><name><surname>Ledin</surname> <given-names>J</given-names></name><name><surname>Burgess</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9</article-title><source>Genome Research</source><volume>25</volume><fpage>1030</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1101/gr.186379.114</pub-id><pub-id pub-id-type="pmid">26048245</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villefranc</surname> <given-names>JA</given-names></name><name><surname>Amigo</surname> <given-names>J</given-names></name><name><surname>Lawson</surname> <given-names>ND</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Gateway compatible vectors for analysis of gene function in the zebrafish</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3077</fpage><lpage>3087</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21354</pub-id><pub-id pub-id-type="pmid">17948311</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldo</surname> <given-names>KL</given-names></name><name><surname>Hutson</surname> <given-names>MR</given-names></name><name><surname>Stadt</surname> <given-names>HA</given-names></name><name><surname>Zdanowicz</surname> <given-names>M</given-names></name><name><surname>Zdanowicz</surname> <given-names>J</given-names></name><name><surname>Kirby</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2005">2005a</year><article-title>Cardiac neural crest is necessary for normal addition of the myocardium to the arterial pole from the secondary heart field</article-title><source>Developmental Biology</source><volume>281</volume><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.02.011</pub-id><pub-id pub-id-type="pmid">15848389</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldo</surname> <given-names>KL</given-names></name><name><surname>Hutson</surname> <given-names>MR</given-names></name><name><surname>Ward</surname> <given-names>CC</given-names></name><name><surname>Zdanowicz</surname> <given-names>M</given-names></name><name><surname>Stadt</surname> <given-names>HA</given-names></name><name><surname>Kumiski</surname> <given-names>D</given-names></name><name><surname>Abu-Issa</surname> <given-names>R</given-names></name><name><surname>Kirby</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2005">2005b</year><article-title>Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart</article-title><source>Developmental Biology</source><volume>281</volume><fpage>78</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2005.02.012</pub-id><pub-id pub-id-type="pmid">15848390</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Kaiser</surname> <given-names>MS</given-names></name><name><surname>Larson</surname> <given-names>JD</given-names></name><name><surname>Nasevicius</surname> <given-names>A</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Wadman</surname> <given-names>SA</given-names></name><name><surname>Roberg-Perez</surname> <given-names>SE</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Hackett</surname> <given-names>PB</given-names></name><name><surname>McGrail</surname> <given-names>M</given-names></name><name><surname>Essner</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Moesin1 and Ve-cadherin are required in endothelial cells during <italic>in vivo</italic> tubulogenesis</article-title><source>Development</source><volume>137</volume><fpage>3119</fpage><lpage>3128</lpage><pub-id pub-id-type="doi">10.1242/dev.048785</pub-id><pub-id pub-id-type="pmid">20736288</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname> <given-names>MR</given-names></name><name><surname>Shuttleworth</surname> <given-names>A</given-names></name><name><surname>Canfield</surname> <given-names>AE</given-names></name><name><surname>Black</surname> <given-names>RA</given-names></name><name><surname>Kielty</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment</article-title><source>Biomaterials</source><volume>28</volume><fpage>5307</fpage><lpage>5318</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2007.08.019</pub-id><pub-id pub-id-type="pmid">17850863</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname> <given-names>H</given-names></name><name><surname>Schluterman</surname> <given-names>MK</given-names></name><name><surname>Brekken</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fibulin-5, an integrin-binding matricellular protein: its function in development and disease</article-title><source>Journal of Cell Communication and Signaling</source><volume>3</volume><fpage>337</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1007/s12079-009-0065-3</pub-id><pub-id pub-id-type="pmid">19798595</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Gu</surname> <given-names>J</given-names></name><name><surname>Xie</surname> <given-names>S</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>H</given-names></name><name><surname>Yao</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Deep mRNA sequencing analysis to capture the transcriptome landscape of zebrafish embryos and larvae</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e64058</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0064058</pub-id><pub-id pub-id-type="pmid">23700457</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>P</given-names></name><name><surname>Schmit</surname> <given-names>BM</given-names></name><name><surname>Fu</surname> <given-names>C</given-names></name><name><surname>DeSart</surname> <given-names>K</given-names></name><name><surname>Oh</surname> <given-names>SP</given-names></name><name><surname>Berceli</surname> <given-names>SA</given-names></name><name><surname>Jiang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>35444</elocation-id><pub-id pub-id-type="doi">10.1038/srep35444</pub-id><pub-id pub-id-type="pmid">27739498</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>LG</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>He</surname> <given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS: A Journal of Integrative Biology</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Hou</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>F</given-names></name><name><surname>Ju</surname> <given-names>R</given-names></name><name><surname>Cheng</surname> <given-names>X</given-names></name><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name><name><surname>Lan</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Smad4 deficiency in smooth muscle cells initiates the formation of aortic aneurysm</article-title><source>Circulation Research</source><volume>118</volume><fpage>388</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.308040</pub-id><pub-id pub-id-type="pmid">26699655</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanistic insight into contextual TGF-β signaling</article-title><source>Current Opinion in Cell Biology</source><volume>51</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.10.001</pub-id><pub-id pub-id-type="pmid">29149681</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Cashman</surname> <given-names>TJ</given-names></name><name><surname>Nevis</surname> <given-names>KR</given-names></name><name><surname>Obregon</surname> <given-names>P</given-names></name><name><surname>Carney</surname> <given-names>SA</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Gu</surname> <given-names>A</given-names></name><name><surname>Mosimann</surname> <given-names>C</given-names></name><name><surname>Sondalle</surname> <given-names>S</given-names></name><name><surname>Peterson</surname> <given-names>RE</given-names></name><name><surname>Heideman</surname> <given-names>W</given-names></name><name><surname>Burns</surname> <given-names>CE</given-names></name><name><surname>Burns</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Latent TGF-β binding protein 3 identifies a second heart field in zebrafish</article-title><source>Nature</source><volume>474</volume><fpage>645</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1038/nature10094</pub-id><pub-id pub-id-type="pmid">21623370</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zygmunt</surname> <given-names>T</given-names></name><name><surname>Gay</surname> <given-names>CM</given-names></name><name><surname>Blondelle</surname> <given-names>J</given-names></name><name><surname>Singh</surname> <given-names>MK</given-names></name><name><surname>Flaherty</surname> <given-names>KM</given-names></name><name><surname>Means</surname> <given-names>PC</given-names></name><name><surname>Herwig</surname> <given-names>L</given-names></name><name><surname>Krudewig</surname> <given-names>A</given-names></name><name><surname>Belting</surname> <given-names>HG</given-names></name><name><surname>Affolter</surname> <given-names>M</given-names></name><name><surname>Epstein</surname> <given-names>JA</given-names></name><name><surname>Torres-Vázquez</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1</article-title><source>Developmental Cell</source><volume>21</volume><fpage>301</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.06.033</pub-id><pub-id pub-id-type="pmid">21802375</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57603.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Meilhac</surname><given-names>Sigolène M</given-names></name><role>Reviewing Editor</role><aff><institution>Imagine-Institut Pasteur</institution><country>France</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Vermot</surname><given-names>Julien</given-names> </name><role>Reviewer</role><aff><institution>Institut de Génétique et de Biologie Moléculaire et Cellulaire</institution><country>France</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Azhar</surname><given-names>Mohamad</given-names> </name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Endothelial cells have largely been neglected in vasculopathies, compared to smooth muscle cells and cardiac neural crests. This work now demonstrates a role of endothelial Alk5 signalling for the correct formation of the outflow tract in the zebrafish. It uncovers the extra-cellular matrix protein fbln5 as an effector, regulating the organization of the smooth muscle layer.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Endothelial TGF-β signaling instructs smooth muscle cell development in the cardiac outflow tract&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Edward Morrisey as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Julien Vermot (Reviewer #2), Mohamad Azhar (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>This is an elegant and well written paper by Boezio et al. showing a role of the TGF-β receptor Alk5 in endothelial cells for the correct formation of the outflow tract/bulbus arteriosus in the zebrafish model. The authors assess the crosstalk between endothelial and smooth muscle cells. In newly generated double <italic>alk5a/b</italic> mutants, the authors show that the abnormal dilation of the outflow tract correlates with an increased number of endothelial cells followed by defective formation of the smooth muscle layer including the extra-cellular-matrix. The cardiovascular defects in <italic>alk5</italic> mutant fish being restricted to the outflow tract and ventral aorta, while all other vascular beds appear morphologically unaffected is remarkable. Transgenic rescue experiments demonstrate that <italic>alk5</italic> in endothelial cells is sufficient, but do not exclude an additional role in smooth muscle cells where <italic>alk5</italic> is also expressed. Transcriptomic analyses of pooled entire hearts, filtered with previous datasets, identify the extra-cellular matrix protein <italic>fbln5</italic> as a potential effector of <italic>alk5</italic>, which is supported by a non-targeted rescue experiment.</p><p>Based on advanced imaging and genetics, the fish appears as a relevant model to decipher potentially pathogenic mechanisms relevant to aorta aneurysm or dissection. Endothelial cells have largely been a neglected cell type in vasculopathies, with available literature predominantly focusing on the role of smooth muscle cells and cardiac neural crests.</p><p>However, several questions need to be addressed to support the main conclusions.</p><p>Revisions for this paper:</p><p>1) Alk5 expression. The main figure shows the expression of Alk5 at 78hpf. The rationale of this particular stage of development is not provided. The claim that &quot;it becomes restricted to the OFT&quot; suggests changes over time. This claim should be altered or more stages provided, the question of whether it is expressed at 36hpf when defects in replicating endothelial cells are shown should be raised. In addition, it is hard to visualize that Alk5 is restricted to the OFT based on the panels presented, it seems to have the same level of expression in the ventricle. A quantitative analysis would help to make the point. As the authors correctly mention in the Introduction, aortic smooth muscle cells, and not endothelial cells, are enriched for Alk5 expression in the mouse. Their data (Figure 1B-B&quot;) also show robust expression in smooth muscle cells. How do they interpret their results in endothelial cells in the light of these findings?</p><p>2) Alk5 signaling. The manuscript does not contain data showing any direct effect on TGF-β signaling. The authors have assumed all along that perturbing <italic>alk5</italic> levels would affect signaling but have not measured levels of phosphorylated Smad2/3 and Smad1/5 in endothelial cells to demonstrate this effect. While immunohistochemistry data for P-Smads would be ideal, the expression of some TGF-β target genes such as Pai1, etc., and reporter containing Smad binding elements (SBE) in isolated <italic>alk5</italic> mutant endothelial cells would be an alternative support of this conclusion. The authors have completely ignored the likely effects of <italic>alk5</italic> deletion on BMP signaling. Bmp2 has been shown to recruit Smad2 via Alk5/7, preferentially in the endothelial and embryonic cells, including in the dorsoventral axis formation in zebrafish (PMID: 24308972). Alternatively, Alk5 is also required for TGF-β's inhibitory effect on BMP signaling (22615489). Since Alk5 rests at the fulcrum of these two important signaling cascades with celebrated involvement in heart development, it would be essential to know in which direction the balance tilts in <italic>alk5</italic> mutants. This should be discussed in the manuscript and potentially supported by the transcriptomics data.</p><p>3) Alk5 mutants. What is the extent of sequence similarity between <italic>alk5a</italic> and <italic>alk5b</italic>? It is unclear why <italic>alk5a</italic> is so important to uncover a phenotype in the absence of <italic>alk5b</italic> if it is not highly expressed during embryogenesis and no compensation is observed between these genes in the respective mutants. Is there an explanation for this? Alk5 mutants display cardiac edema but it is unclear if the mutants display defective cardiac functions and at what stage? Since the data available in Video 3 is very limited, whether <italic>alk5</italic> mutants display normal beating of the heart and intracardiac blood flow remains unanswered.</p><p>4) In the transcriptomic dataset, how is Eln2, used in previous figures, and <italic>alk1</italic>, mentioned in the Discussion ? Why adhesion proteins, potentially relevant to the leaky endothelium or absence of the VA are not considered ?</p><p>5) Fbln5. The tissue layer where <italic>fbln5</italic> is expressed should be easily accessible using fluorescent ISH. Is <italic>fbln5</italic> expressed at 36hpf, before the smooth muscle coverage ? How is the VA in Alk5 mutants injected with <italic>fbln5</italic> mRNA ? The rescue of <italic>eln2</italic> organisation requires quantification.</p><p>6) The photoconversion experiments are amazing. Yet the conclusions may be overstated. It reads that <italic>alk5</italic> regulates cell displacement in the OFT. The term cell displacement may be a bit confusing as the VA is not forming in <italic>alk5</italic> mutant and it is unclear how this is actually related to the cell displacement observed in the control at this point. The VA absence could just arrest any morphogenetic processes. The mechanism of VA formation is not introduced and should be discussed.</p><p>Revisions expected in follow-up work:</p><p>1) Alk5 expression. To support the conclusion that &quot;<italic>alk5</italic> expression becomes restricted to the OFT&quot;, several time points are required and especially from which time point the expression of Alk5 starts, and whether it is expressed at 36hpf when defects in replicating endothelial cells are shown.</p><p>2) Alk5 signaling. While immunohistochemistry data for P-Smads would be ideal, the expression of some TGF-β target genes such as Pai1, etc., and reporter containing Smad binding elements (SBE) in isolated <italic>alk5</italic> mutant endothelial cells would be an alternative support of this conclusion. The authors should consider likely effects of <italic>alk5</italic> deletion on BMP signaling.</p><p>3) Alk5 mutants. To what extent is <italic>alk5</italic> expression perturbed in the smooth muscle cells of the mutant fish? Also, is the smooth muscle cell proliferation defect rescued upon <italic>alk5</italic> overexpression in the mutants?</p><p>4) The transcriptomic dataset is validated for a single gene. The validation should be extended to the 5 genes selected in Figure 5C, as well as Alk5 responsive genes.</p><p>5) Fbln5. How is <italic>fbln5</italic> expression in the <italic>alk5</italic> mutants rescued with endothelial <italic>alk5b</italic>?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57603.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Revisions for this paper:</p><p>1) Alk5 expression. The main figure shows the expression of Alk5 at 78hpf. The rationale of this particular stage of development is not provided. The claim that &quot;it becomes restricted to the OFT&quot; suggests changes over time. This claim should be altered or more stages provided, the question of whether it is expressed at 36hpf when defects in replicating endothelial cells are shown should be raised. In addition, it is hard to visualize that Alk5 is restricted to the OFT based on the panels presented, it seems to have the same level of expression in the ventricle. A quantitative analysis would help to make the point. As the authors correctly mention in the Introduction, aortic smooth muscle cells, and not endothelial cells, are enriched for Alk5 expression in the mouse. Their data (Figure 1B-B&quot;) also show robust expression in smooth muscle cells. How do they interpret their results in endothelial cells in the light of these findings?</p></disp-quote><p>We fully agree with the reviewers that information about the localization and timing of <italic>alk5b</italic> expression is important for the overall understanding of the mutant phenotype. We previously focused on its expression starting at 78 hpf because it is when the mutant phenotype becomes obvious, and also it is when the OFT becomes easily accessible for live imaging. Moreover, and unfortunately, the <italic>alk5b</italic> BAC reporter line displays an extremely low signal, consistent with the low expression of the gene, making the imaging – especially at early stages – particularly challenging. However, we have now been able to observe a weak signal throughout the heart at 36 hpf (green, <xref ref-type="fig" rid="respfig1">Author response image 1</xref>).</p><fig id="respfig1"><label>Author response image 1.</label><caption><title><italic>Tg(alk5b:</italic>EGFP) expression (green) at 36 hpf.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-resp-fig1-v1.tif"/></fig><p>In order to overcome these technical limitations, we used TGF-β signaling reporters. We imaged the Smad3 responsive element reporter line (<italic>Tg(12xSBE:EGFP)</italic>) – used as a proxy for Smad3 activation – and performed p-Smad3 antibody staining. With both of these approaches, we obtained evidence for TGF-β signaling in OFT ECs at 24 hpf (Figure 2 and Figure 2—figure supplement 1). Notably, p-Smad3 antibody staining showed an enrichment in OFT ECs at 24 hpf (Figure 2A-C), which, interestingly, was lost by 75 hpf (Figure 2B, Figure 2—figure supplement 1C, C’).</p><p>Based on these new findings, we propose that the early endothelial phenotype we observed in <italic>alk5</italic> mutants can be explained by the early Smad3 activation specifically in ECs. Subsequently, TGF-β signaling activity can be observed in SMCs. We speculate that a similar pattern might occur in mammals, where the early activation of TGF-β signaling in endothelial cells might have been overlooked. It is also worth noting that while <italic>alk5</italic>/Alk5 expression might be broad and weak, the expression of downstream factors might be more limited, thereby contributing to restrict the activation of the pathway.</p><disp-quote content-type="editor-comment"><p>2) Alk5 signaling. The manuscript does not contain data showing any direct effect on TGF-β signaling. The authors have assumed all along that perturbing alk5 levels would affect signaling but have not measured levels of phosphorylated Smad2/3 and Smad1/5 in endothelial cells to demonstrate this effect. While immunohistochemistry data for P-Smads would be ideal, the expression of some TGF-β target genes such as Pai1, etc., and reporter containing Smad binding elements (SBE) in isolated alk5 mutant endothelial cells would be an alternative support of this conclusion. The authors have completely ignored the likely effects of alk5 deletion on BMP signaling. Bmp2 has been shown to recruit Smad2 via Alk5/7, preferentially in the endothelial and embryonic cells, including in the dorsoventral axis formation in zebrafish (PMID: 24308972). Alternatively, Alk5 is also required for TGF-β's inhibitory effect on BMP signaling (22615489). Since Alk5 rests at the fulcrum of these two important signaling cascades with celebrated involvement in heart development, it would be essential to know in which direction the balance tilts in alk5 mutants. This should be discussed in the manuscript and potentially supported by the transcriptomics data.</p></disp-quote><p>We agree with the reviewers that assessing TGF-β signaling is a crucial point and thank them for the constructive suggestions. We have now performed p-Smad3 antibody staining at 24 hpf, i.e., before the onset of the phenotype, and detected a significant reduction of the signal in <italic>alk5</italic>-/- OFTs, in both ECs and surrounding cells (Figure 2D-F). We have also investigated the effect of Smad3 inhibition in OFT development (Figure 2G-K), and found that it is sufficient to induce a mild OFT phenotype in <italic>alk5</italic> heterozygotes (Figure 2G-H), and that it exacerbates the already severe phenotype in <italic>alk5</italic> mutants (Figure 2I-J).</p><p>We have also addressed in the Results section the potential role of Alk5 in regulating BMP signaling. Since the antibody staining for p-Smad1/5/8, now included in Figure 2—figure supplement 1F-I, did not show any significant enrichment in OFT ECs or significant difference between <italic>alk5+/+</italic> and <italic>alk5</italic>-/- OFTs, we propose that BMP signaling does not play a major role in OFT development, at least at early stages.</p><disp-quote content-type="editor-comment"><p>3) Alk5 mutants. What is the extent of sequence similarity between alk5a and alk5b? It is unclear why alk5a is so important to uncover a phenotype in the absence of alk5b if it is not highly expressed during embryogenesis and no compensation is observed between these genes in the respective mutants. Is there an explanation for this? Alk5 mutants display cardiac edema but it is unclear if the mutants display defective cardiac functions and at what stage? Since the data available in Video 3 is very limited, whether alk5 mutants display normal beating of the heart and intracardiac blood flow remains unanswered.</p></disp-quote><p>Alk5a and Alk5b display a very high level of sequence similarity (<xref ref-type="fig" rid="respfig2">Author response image 2</xref>) in their intracellular domains (amino acids: 177-end), while they differ in their extracellular domains. <italic>alk5a</italic> mRNA levels are low at embryonic and larval stages; however, we have no information about protein levels in wild types or in <italic>alk5b</italic>-/- fish.</p><fig id="respfig2"><label>Author response image 2.</label><caption><title>Clustal Omega (Madeira et al., 2019) protein alignment of Alk5a (B0EXP6_DANRE) and Alk5b (F1QQ20_DANRE).</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-resp-fig2-v1.tif"/></fig><p>Following the reviewers’ suggestion, we have now added information regarding <italic>alk5-/-</italic> cardiac function in the revised manuscript. We have measured the heart rate and found no significant differences even at 78 hpf, a stage when the OFT phenotype is already severe (Figure 1—figure supplement 1P), indicating that cardiac rhythm is not affected in <italic>alk5</italic> mutants. Nonetheless, at the same stage we observed in <italic>alk5</italic> mutants a consistent blood regurgitation in the AV canal compared with wild type (1/6 <italic>alk5+/+</italic>, 9/10 <italic>alk5-/-</italic>). We have now modified the Results section to include this information.</p><disp-quote content-type="editor-comment"><p>4) In the transcriptomic dataset, how is Eln2, used in previous figures, and alk1, mentioned in the Discussion ? Why adhesion proteins, potentially relevant to the leaky endothelium or absence of the VA are not considered ?</p></disp-quote><p>We agree with the reviewers that analyzing adhesion proteins will be interesting in future studies. However, in this work, we aimed to identify factors mediating the interaction between ECs and SMCs and, thus, selected proteins that could be secreted by ECs, or ligand-receptors which could mediate this cross-talk.</p><p>Following the reviewers’ comments, we have now measured in dissected 72 hpf <italic>alk5+/+</italic> and <italic>alk5-/-</italic> hearts the mRNA levels of the 5 genes selected from the intersection of the different datasets (Figure 6—figure supplement 1D). The new results can be found in Figure 6—figure supplement 1E. Moreover, we assessed <italic>elnb</italic> and <italic>alk1</italic> mRNA levels (<xref ref-type="fig" rid="respfig3">Author response image 3</xref>) and found a slight downregulation in <italic>alk5-/-</italic> hearts, similar to what was observed in the RNAseq dataset on larval hearts from Alk5 inhibitor-treated animals (<italic>elnb:</italic> log2FC -2.41;; <italic>alk1</italic>: log2FC -0.48).</p><fig id="respfig3"><label>Author response image 3.</label><caption><title><italic>elnb</italic> and <italic>alk1</italic> expression in 72 hpf <italic>alk5+/+</italic> and <italic>alk5-/-</italic> hearts (p values from Mann Whitney tests).</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57603-resp-fig3-v1.tif"/></fig><p>In order to validate Alk5 responsive genes, we analyzed the Gene Ontology category “response to TGF-β” and only found genes belonging to the pathway (including <italic>smad7, skia, skib, skilb, skila,</italic> and <italic>alk5b</italic> itself), the expression of which has been shown to be reinforced in a positive feedback loop (Yan et al., 2018). Regarding TGF-β target genes commonly used in the literature, we observed a very diverse response in terms of expression in the RNA-seq dataset (Author response table 1), which might be due to secondary effects deriving from the OFT defects or to lack of tissue resolution (i.e., some genes might be TGF-β targets in some cardiac tissues and not in others). For all the above-mentioned genes, considering that we could not extract hearts and OFTs at 24-36 hpf (i.e., before the onset of the phenotype) due to technical limitations, we decided not to assess their mRNA levels at later stages, because of possible secondary effects.</p><p>However, for the sake of clarity, we added Supplementary file 1 with all the genes up- or down-regulated (&gt;1 or &lt;-1 log2FC) in the RNAseq.</p><table-wrap id="resptable1" position="float"><label>Author response table 1.</label><caption><title>Expression of some bona fide TGF-β targets in 56 hpf hearts from DMSO treated vs.Alk5 inhibitor treated larvae.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Base Mean DMSO</th><th>Base Mean Inhibitor</th><th>Log2FC Inhib/DMSO</th></tr></thead><tbody><tr valign="top"><td><italic>loxa</italic></td><td>750</td><td>353</td><td>-1.08</td></tr><tr valign="top"><td><italic>ctgfa</italic></td><td>2672</td><td>1252</td><td>-1.09</td></tr><tr valign="top"><td><italic>serpine1</italic></td><td>244</td><td>915</td><td>1.90</td></tr><tr valign="top"><td><italic>acta2</italic></td><td>588</td><td>2171</td><td>1.88</td></tr><tr valign="top"><td><italic>junba</italic></td><td>238</td><td>361</td><td>0.60</td></tr><tr valign="top"><td><italic>junbb</italic></td><td>567</td><td>608</td><td>0.10</td></tr></tbody></table></table-wrap><disp-quote content-type="editor-comment"><p>5) Fbln5. The tissue layer where <italic>fbln5</italic> is expressed should be easily accessible using fluorescent ISH. Is <italic>fbln5</italic> expressed at 36hpf, before the smooth muscle coverage ? How is the VA in Alk5 mutants injected with <italic>fbln5</italic> mRNA ? The rescue of eln2 organisation requires quantification.</p></disp-quote><p>We understand the reviewers’ questions about <italic>fbln5</italic> expression, and have now included new data showing that <italic>fbln5</italic> is indeed expressed in OFT ECs (Figure 6 and Figure 6—figure supplement 2).</p><p>1) We performed ISH and fluorescent ISH at 36 hpf, before SMC coverage of OFT, and observed <italic>fbln5</italic> expression in OFT ECs (Figure 6C-C’; Figure 6—figure supplement 2A-B’).</p><p>2) We generated a new EC-specific <italic>Tg(fli1a:fbln5,EGFP)</italic> line and found a partial rescue of a) OFT expansion, b) Eln2 organization, and c) VA formation in <italic>alk5</italic> mutants carrying this transgene (Figure 6D-K).</p><p>3) We performed additional RT-qPCR experiments and observed an increase in <italic>fbln5</italic> expression in <italic>Tg(fli1a:alk5b-mScarlet) alk5-/-</italic> hearts, compared with <italic>alk5-/-</italic> hearts not carrying the rescue transgene (Figure 6—figure supplement 2C).</p><p>Thus, these data strengthen our claim that Fbln5 can function downstream of Alk5 in ECs to regulate OFT development.</p><disp-quote content-type="editor-comment"><p>6) The photoconversion experiments are amazing. Yet the conclusions may be overstated. It reads that Alk5 regulates cell displacement in the OFT. The term cell displacement may be a bit confusing as the VA is not forming in <italic>alk5</italic> mutant and it is unclear how this is actually related to the cell displacement observed in the control at this point. The VA absence could just arrest any morphogenetic processes. The mechanism of VA formation is not introduced and should be discussed.</p></disp-quote><p>We thank the reviewers for the constructive comments and agree on the importance of distinguishing among these various possibilities. We appreciate that the time-lapse imaging alone is not a conclusive proof in terms of active cell movements, and that the lack of VA could be due to defects in other processes. Therefore, we have now refrained from using terms such as “migration” and “displacement”, and toned down our conclusions on the causes leading to the VA defects. We have rephrased the Results and Discussion sections accordingly.</p><disp-quote content-type="editor-comment"><p>Revisions expected in follow-up work:</p><p>1) Alk5 expression. To support the conclusion that &quot;alk5 expression becomes restricted to the OFT&quot;, several time points are required and especially from which time point the expression of Alk5 starts, and whether it is expressed at 36hpf when defects in replicating endothelial cells are shown.</p></disp-quote><p>Please see Revisions for this paper, point 1.</p><disp-quote content-type="editor-comment"><p>2) Alk5 signaling. While immunohistochemistry data for P-Smads would be ideal, the expression of some TGF-β target genes such as Pai1, etc., and reporter containing Smad binding elements (SBE) in isolated alk5 mutant endothelial cells would be an alternative support of this conclusion. The authors should consider likely effects of alk5 deletion on BMP signaling.</p></disp-quote><p>Please see Revisions for this paper, point 2.</p><disp-quote content-type="editor-comment"><p>3) Alk5 mutants. To what extent is alk5 expression perturbed in the smooth muscle cells of the mutant fish? Also, is the smooth muscle cell proliferation defect rescued upon alk5 overexpression in the mutants?</p></disp-quote><p>Please see Revisions for this paper, point 3.</p><disp-quote content-type="editor-comment"><p>4) The transcriptomic dataset is validated for a single gene. The validation should be extended to the 5 genes selected in Figure 5C, as well as Alk5 responsive genes.</p></disp-quote><p>Please see Revisions for this paper, point 4.</p><disp-quote content-type="editor-comment"><p>5) Fbln5. How is fbln5 expression in the alk5 mutants rescued with endothelial alk5b?</p></disp-quote><p>Please see Revisions for this paper, point 5.</p><p>References:</p><p>Madeira, F., Park, Y. M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N., ... Lopez, R. (2019). The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res, 47(W1), W636-W641. doi:10.1093/nar/gkz268</p><p>Smyth, L. C. D., Rustenhoven, J., Scotter, E. L., Schweder, P., Faull, R. L. M., Park, T. I. H., and Dragunow, M. (2018). Markers for human brain pericytes and smooth muscle cells. J Chem Neuroanat<italic>, 92</italic>, 48-60. doi:10.1016/j.jchemneu.2018.06.001</p><p>Yan, X., Xiong, X., and Chen, Y. G. (2018). Feedback regulation of TGF-beta signaling. Acta Biochim Biophys Sin (Shanghai), 50(1), 37-50. doi:10.1093/abbs/gmx129</p></body></sub-article></article>